StartDate,EndDate,Status,IPAddress,Progress,Duration (in seconds),Finished,RecordedDate,ResponseId,RecipientLastName,RecipientFirstName,RecipientEmail,ExternalReference,LocationLatitude,LocationLongitude,DistributionChannel,UserLanguage,Q1,Q17,Q15,Q7,Q8,Q9,Q10,Q11,Q12,Q13,Q14,Q18,11,Login ID
Start Date,End Date,Response Type,IP Address,Progress,Duration (in seconds),Finished,Recorded Date,Response ID,Recipient Last Name,Recipient First Name,Recipient Email,External Data Reference,Location Latitude,Location Longitude,Distribution Channel,User Language,Name of Key Program,Acronym for key program,Focus Area (select all that apply),DOC,Primary Contact (PI),Primary Contact (PI) email,NIH Contact (Program Officer/Program Director),NIH Contact (Program Officer/Program Director) email,"NOFO number (eg. format as ""RFA-CA-00-000"") (If more than one, separate with ; semicolon)","Grant/Award number {parent award FORMAT LL#CA######, eg. UG3CA260607} (If more than one, separate with ; semicolon)",Link to program website,Link to data or DCC if available,"What type of cancer is the primary focus of the program? (Check all that
apply)",Login ID
7/18/2023 14:30,7/18/2023 14:41,IP Address,73.130.95.160,100,680,TRUE,7/18/2023 14:41,R_b29WNmDDM4Nhd7j,,,,,40.0756,-76.6914,anonymous,EN,The Early Detection Research Network (EDRN),EDRN,,DCP,,,"MARQUEZ, GUILLERMO; SORBARA, LYNN R",gm186p@nih.gov; lynns@mail.nih.gov,CA-14-017;CA-21-034;CA-21-033;CA-21-035;CA-14-015;CA-14-016;CA-16-009,,https://edrn.nci.nih.gov/,https://edrn.nci.nih.gov/data-and-resources/data/,This program focuses on cancer broadly - not limited to a primary cancer type,190484
7/18/2023 14:43,7/18/2023 14:44,IP Address,73.130.95.160,100,43,TRUE,7/18/2023 14:44,R_0pT1g50QqcEx2VP,,,,,40.0756,-76.6914,anonymous,EN,Cancer Prevention-Interception Targeted Agent Discovery Program,CAP-IT,,DCP,,,"Sei, Shizuko",shizuko.sei@nih.gov,RFA-CA-21-038;RFA-CA-22-055;RFA-CA-21-039,,https://prevention.cancer.gov/major-programs/cancer-prevention-interception-targeted-agent-discovery-program,,This program focuses on cancer broadly - not limited to a primary cancer type,556874
7/31/2023 9:31,7/31/2023 10:44,IP Address,128.231.234.20,100,4398,TRUE,7/31/2023 10:44,R_1BVldgCxHAnJ4iJ,,,,,39.0462,-77.1195,anonymous,EN,Genomic Data Analysis Network,GDAN,,CCG,,,"LIMING, YANG",lyang@mail.nih.gov,RFA-CA-20-053; RFA-CA-15-020; RFA-CA-15-019; RFA-CA-15-018,,https://docs.gdc.cancer.gov/Encyclopedia/pages/Genomic_Data_Analysis_Network/,,This program focuses on cancer broadly - not limited to a primary cancer type,418400
8/1/2023 5:40,8/1/2023 7:24,IP Address,73.130.95.160,100,6270,TRUE,8/1/2023 7:24,R_XvyAFR3tOX4II9z,,,,,40.0756,-76.6914,anonymous,EN,THE CHERNOBYL TISSUE BANK - COORDINATING CENTER,THE CHERNOBYL TISSUE BANK - COORDINATING CENTER,,DCEG,,,"YASSIN, RIHAB R.",ry38k@nih.gov,CA16-502;CA12-501,,https://www.chernobyltissuebank.com/,,Thyroid Cancer,190427
8/2/2023 12:56,8/2/2023 12:58,IP Address,128.231.234.26,100,124,TRUE,8/2/2023 12:58,R_21tzV4xoiX11RWm,,,,,39.0462,-77.1195,anonymous,EN,Cancer Prevention Clinical Trials Network (CP-CTNet),CP-CTNet,,DCP,,,"JOHNSEY, DONALD",dj156d@nih.gov,CA-18-030;CA-18-029;CA-19-031,,https://prevention.cancer.gov/major-programs/cancer-prevention-clinical-trials-network-cp-ctnet,https://www.cp-ctnet-dmacc.org/public/program-resources/,This program focuses on cancer broadly - not limited to a primary cancer type,204710
8/7/2023 7:51,8/7/2023 7:52,IP Address,73.130.95.160,100,68,TRUE,8/7/2023 7:52,R_33kbsTWRiHV0EX4,,,,,40.0756,-76.6914,anonymous,EN,The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST),ALCHEMIST,,DCTD,,,"MOONEY, MARGARET M",mooneym@mail.nih.gov,,U10CA180821;U10CA180830;U10CA031946,https://www.cancer.gov/types/lung/research/alechmist-launch-qa,,Lung Cancer,736643
8/29/2023 5:13,8/30/2023 13:09,IP Address,128.231.234.1,100,114967,TRUE,8/30/2023 13:09,R_xr7mFOV47zMcVLX,,,,,39.0042,-77.1075,anonymous,EN,The Experimental Therapeutics Clinical Trials Network ,ETCTN,,DCTD,,,"IVY, S PERCY",ivyp@ctep.nci.nih.gov,CA19-008;CA19-007;CA15-501;CA-13-006;CA-07-031;CA-02-011,,https://ctep.cancer.gov/initiativesprograms/etctn.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,339909
12/28/2023 9:23,12/28/2023 9:23,IP Address,73.130.95.160,100,27,TRUE,12/28/2023 9:23,R_73yzMNL2fZGUJYN,,,,,40.1025,-76.0761,anonymous,EN, Small Cell Lung Cancer (SCLC) Consortium ,SCLC,,DCP,,,"UJHAZY, PETER",ujhazyp@mail.nih.gov,PAR21-346;PAR-16-049;PAR-16-050;PAR-16-051;PAR-19-361,,https://prevention.cancer.gov/major-programs/small-cell-lung-cancer-sclc-consortium,https://www.mskcc.org/research-programs/nci-small-cell-lung-cancer-consortium/cellminer-sclc,Lung Cancer,911580
12/28/2023 9:35,12/28/2023 9:36,IP Address,73.130.95.160,100,39,TRUE,12/28/2023 9:36,R_1r6W248cpZPWWPH,,,,,40.1025,-76.0761,anonymous,EN,Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer,SPORE - Gastrointestinal,SPORE,DCTD,,,"NOTHWEHR, STEVEN F",nothwehrs@mail.nih.gov,,P50CA127003,https://trp.cancer.gov/spores/abstracts/dfhcc_gi.htm,,Gastric Cancer,831710
12/28/2023 9:38,12/28/2023 9:38,IP Address,73.130.95.160,100,10,TRUE,12/28/2023 9:38,R_3jSYDo0uE4yBSAY,,,,,40.1025,-76.0761,anonymous,EN,HIV-Associated Malignancy Research Centers,HAMRCs,"HIV/AIDS,Health Disparities",OHAM,,,Geraldina Dominguez,domingug@mail.nih.gov,RFA-CA-20-001; RFA-CA-22-011,,https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/research-africa,,This program focuses on cancer broadly - not limited to a primary cancer type,264663
12/28/2023 9:39,12/28/2023 9:39,IP Address,73.130.95.160,100,6,TRUE,12/28/2023 9:39,R_699W9jh6t0ezpuo,,,,,40.1025,-76.0761,anonymous,EN,AIDS and Cancer Specimen Resource (ACSR),ACSR,HIV/AIDS,OHAM,,,Rebecca Liddell Huppi,liddellr@mail.nih.gov,RFA-CA-18-012,,https://acsr1.com/,,,194679
12/28/2023 9:45,12/28/2023 9:46,IP Address,73.130.95.160,100,38,TRUE,12/28/2023 9:46,R_3kn2xslKd5DbSPw,,,,,40.1025,-76.0761,anonymous,EN,Pancreatic Adenocarcinoma Stromal Reprograming ConSortium (PSRC/PASSCODE),PSRC,,"DCB,DCTD","MAITRA, ANIRBAN",amaitra@mdanderson.org,"UJHAZY, PETER",ujhazyp@mail.nih.gov,RFA-CA-21-041; RFA-CA-21-042,,https://www.nci-psrc.org/index.html#Home,https://www.nci-psrc.org/team_MDACC.html,Pancreas Cancer,771645
12/28/2023 9:48,12/28/2023 9:48,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 9:48,R_7n7Z9jW0QVAcIxj,,,,,40.1025,-76.0761,anonymous,EN,Metabolic Dysregulation and Cancer Risk Program,Metabolic Dysregulation and Cancer Risk Program,,"CRCHD,DCB,DCCPS,DCP",,,"LAM, TRAM K",lamt@mail.nih.gov,CA21-022;CA21-021,,https://medoc.bsc.gwu.edu/web/medoc,,This program focuses on cancer broadly - not limited to a primary cancer type,874349
12/28/2023 9:49,12/28/2023 9:50,IP Address,73.130.95.160,100,20,TRUE,12/28/2023 9:50,R_7xVCMWpRc6r538Z,,,,,40.1025,-76.0761,anonymous,EN,Cellular Senescence Network,SenNET,,NIH/OD,,,"JHAPPAN, CHAMELLI",jhappanc@mail.nih.gov,RM21-010;RM21-009;RM21-008,,https://sennetconsortium.org/about-2/,https://data.sennetconsortium.org/search?size=n_10000_n&sort%5B0%5D%5Bfield%5D=last_modified_timestamp&sort%5B0%5D%5Bdirection%5D=desc,This program focuses on cancer broadly - not limited to a primary cancer type,255098
12/28/2023 9:54,12/28/2023 9:56,IP Address,73.130.95.160,100,114,TRUE,12/28/2023 9:56,R_1ZIyNeB5FNeykta,,,,,40.1025,-76.0761,anonymous,EN,PRE-medical Cancer Immunotherapy Network Canine Trials,PRECINCT,,DCTD,,,"SOMMERS, CONNIE L",sommersc@mail.nih.gov,CA21-051;CA21-050,,https://www.precinctnetwork.org/,https://caninecommons.cancer.gov/#/,This program focuses on cancer broadly - not limited to a primary cancer type,580058
12/28/2023 9:57,12/28/2023 9:57,IP Address,73.130.95.160,100,15,TRUE,12/28/2023 9:57,R_5ccKt3QSAf70cn2,,,,,40.1025,-76.0761,anonymous,EN,ILLUMINATING THE DRUGGABLE GENOME,IDG,,NIH/OD,,,"LI, JERRY",jerry.li@nih.gov,RM16-024;RM16-025;RM16-026,,https://commonfund.nih.gov/idg,https://druggablegenome.net/DataTools,This program focuses on cancer broadly - not limited to a primary cancer type,262219
12/28/2023 9:59,12/28/2023 9:59,IP Address,73.130.95.160,100,23,TRUE,12/28/2023 9:59,R_36T2NsKKDIxcIbT,,,,,40.1025,-76.0761,anonymous,EN,Translational and Basic Science Research in Early Lesions,TBEL,,"DCB,DCP",,,"PATRIOTIS, CHRISTOS F",patriotisc@mail.nih.gov,CA21-055;CA21-054,,https://www.tbelprogram.org/index.html,,This program focuses on cancer broadly - not limited to a primary cancer type,260770
12/28/2023 10:23,12/28/2023 10:24,IP Address,73.130.95.160,100,84,TRUE,12/28/2023 10:24,R_7UKAc8s0r3TX7H3,,,,,40.1025,-76.0761,anonymous,EN,Cancer Genome Characterization Initiative,CGCI,,CCG,,,"Komschlies Mcconvill, Kristin",komschkr@mail.nih.gov,,261200800001E-52-0-113;261201500003I-0-26100065-1 ,https://www.cancer.gov/ccg/research/genome-sequencing/cgci,https://portal.gdc.cancer.gov/exploration?filters=%7B%22op%22%3A%22and%22%2C%22content%22%3A%5B%7B%22op%22%3A%22in%22%2C%22content%22%3A%7B%22field%22%3A%22cases.project.program.name%22%2C%22value%22%3A%5B%22CGCI%22%5D%7D%7D%5D%7D,This program focuses on cancer broadly - not limited to a primary cancer type,326410
12/28/2023 10:26,12/28/2023 10:26,IP Address,73.130.95.160,100,6,TRUE,12/28/2023 10:26,R_1MFscAOpFHS9Dqx,,,,,40.1025,-76.0761,anonymous,EN,HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network,CASCADE,HIV/AIDS,DCP,,,"Sahasrabuddhe, Vikrant",vikrant.sahasrabuddhe@nih.gov,CA-21-045;CA-21-046;CA-21-047;CA-22-051,,https://prevention.cancer.gov/major-programs/hiv-cervical-cancer-prevention-cascade-clinical-trials-network,,Cervical Cancer,838706
12/28/2023 10:26,12/28/2023 10:28,IP Address,73.130.95.160,100,103,TRUE,12/28/2023 10:28,R_3qTLqV7JyBSQnZi,,,,,40.1025,-76.0761,anonymous,EN,Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer,SPORE - Breast Cancer - DF/HCC,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA168504,https://trp.cancer.gov/spores/abstracts/dfhcc_breast.htm,,Breast Cancer,346541
12/28/2023 10:29,12/28/2023 10:30,IP Address,73.130.95.160,100,10,TRUE,12/28/2023 10:30,R_6oZ6qWlPlrBBZO6,,,,,40.1025,-76.0761,anonymous,EN,Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant,SPORE Ovarian Cancer - DF/HCC,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA240243,https://trp.cancer.gov/spores/abstracts/dfhcc_ovarian.htm,,Ovarian Cancer,927418
12/28/2023 10:35,12/28/2023 10:35,IP Address,73.130.95.160,100,6,TRUE,12/28/2023 10:35,R_7Bksye2LxaGjd7M,,,,,40.1025,-76.0761,anonymous,EN,City of Hope Lymphoma SPORE,SPORE - Lymphoma,SPORE,DCTD,,,"kuzmin, Igor",kuzmini@mail.nih.gov,,P50CA107399,https://www.cityofhope.org/research/hematologic-malignancies-research-institute/lymphoma-spore,,Lymphoma,692098
12/28/2023 10:37,12/28/2023 10:40,IP Address,73.130.95.160,100,161,TRUE,12/28/2023 10:40,R_7ozRLNyxLy8Btij,,,,,40.1025,-76.0761,anonymous,EN,Connecting Underrepresented Populations to Clinical Trials (CUSP2CT),CUSP2CT,Health Disparities,CRCHD,,,"Stewart, Whitney; San Miguel-Majors, Sandra L. ",whitney.barfield@nih.gov,RFA-CA-21-063; RFA-CA-21-058; RFA-CA-22-014,,https://www.cancer.gov/about-nci/organization/crchd/inp/cusp2ct,,This program focuses on cancer broadly - not limited to a primary cancer type,141372
12/28/2023 10:40,12/28/2023 10:41,IP Address,73.130.95.160,100,22,TRUE,12/28/2023 10:41,R_6cUZEy6dHWBqxqN,,,,,40.1025,-76.0761,anonymous,EN,Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes,ENICTO,,DCCPS,"Evans, Scott; Robien, Kim",sevans@bsc.gwu.edu; krobien@gwu.edu,"Perna, Frank; Agurs-Collins, Tanya",pernafm@mail.nih.gov,RFA-CA-21-032; RFA-CA-21-031,,https://enicto.bsc.gwu.edu/web/enicto,https://enicto.bsc.gwu.edu/web/enicto/coordinating-center,This program focuses on cancer broadly - not limited to a primary cancer type,625761
12/28/2023 10:42,12/28/2023 10:43,IP Address,73.130.95.160,100,33,TRUE,12/28/2023 10:43,R_7dWHjxGO7j8e6KR,,,,,40.1025,-76.0761,anonymous,EN,Cancer Systems Biology Consortium (CSBC),CSBC,,DCB,,,"Dueck, Hannah; Zamisch, Monica; HUGHES, SHANNON K",hannah.dueck@nih.gov,RFA-CA-15-015; RFA-CA-21-049; RFA-CA-21-048; RFA-CA-15-014; PAR-16-131; PAR-19-287,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc,https://www.cancercomplexity.synapse.org/,This program focuses on cancer broadly - not limited to a primary cancer type,626289
12/28/2023 10:47,12/28/2023 10:47,IP Address,73.130.95.160,100,28,TRUE,12/28/2023 10:47,R_5h6pztfFEHoJc0d,,,,,40.1025,-76.0761,anonymous,EN,A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research,CIBMTR (Data Resource),,DCTD,,,"HOROWITZ, MARY MARESCA",marymh@mcw.edu,CA-12-503;CA-17-031;CA-22-026,,https://cibmtr.org/,https://cibmtr.org/CIBMTR/Resources/Publicly-Available-Datasets#,"This program focuses on cancer broadly - not limited to a primary cancer type,Leukemia,Lymphoma",408821
12/28/2023 10:52,12/28/2023 10:53,IP Address,73.130.95.160,100,8,TRUE,12/28/2023 10:53,R_7gzQUZBTxjUtCyl,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Gastrointestinal Cancers,SPORE Gastrointestinal Cancer - JHU,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA062924,https://trp.cancer.gov/spores/abstracts/johnshopkins_gi.htm,,Gastric Cancer,205473
12/28/2023 10:53,12/28/2023 10:53,IP Address,73.130.95.160,100,5,TRUE,12/28/2023 10:53,R_7HSd8QYXRP2xtn3,,,,,40.1025,-76.0761,anonymous,EN,Epigenetic Therapies - New Approaches,SPORE Epigenetics,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA254897,https://trp.cancer.gov/spores/abstracts/coriell_institute_epigenetics.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,764553
12/28/2023 10:54,12/28/2023 10:54,IP Address,73.130.95.160,100,12,TRUE,12/28/2023 10:54,R_7lYzOTxZgBzml57,,,,,40.1025,-76.0761,anonymous,EN,Emory University Lung Cancer SPORE,SPORE Lung Cancer - Emory,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA217691,https://trp.cancer.gov/spores/abstracts/emory_lung.htm,,Lung Cancer,309827
12/28/2023 10:55,12/28/2023 10:55,IP Address,73.130.95.160,100,8,TRUE,12/28/2023 10:55,R_3t6u8c5AjdALJAJ,,,,,40.1025,-76.0761,anonymous,EN,MSK SPORE in Genomic Instability in Breast Cancer,SPORE Breast Cancer - MSK,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA247749,https://trp.cancer.gov/spores/abstracts/mskcc_breast.htm,,Breast Cancer,528130
12/28/2023 10:55,12/28/2023 10:57,IP Address,73.130.95.160,100,69,TRUE,12/28/2023 10:57,R_7rIGy7Rv5cwVUqs,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Breast Cancer,SPORE Breast Cancer - Vanderbilt,SPORE,DCTD,,,"COURTNEY, JOYANN",joyann.rohan@nih.gov,,P50CA098131,https://trp.cancer.gov/spores/abstracts/vanderbilt_breast.htm,,Breast Cancer,134835
12/28/2023 10:57,12/28/2023 10:58,IP Address,73.130.95.160,100,37,TRUE,12/28/2023 10:58,R_5PgIRYcVsXHXOD9,,,,,40.1025,-76.0761,anonymous,EN,University of North Carolina SPORE in Breast Cancer,SPORE Breast Cancer - UNC,SPORE,DCTD,,,"COURTNEY, JOYANN",joyann.rohan@nih.gov,,P50CA058223,https://trp.cancer.gov/spores/abstracts/unc_breast.htm,,Breast Cancer,767036
12/28/2023 10:58,12/28/2023 10:59,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 10:59,R_3lrC07go34IN7Gx,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Lung Cancer - The University of Texas MD Anderson Cancer Center ,SPORE Lung Cancer - Texas,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA070907,https://trp.cancer.gov/spores/abstracts/utsouthwestern_lung.htm,,Lung Cancer,618842
12/28/2023 11:00,12/28/2023 11:00,IP Address,73.130.95.160,100,18,TRUE,12/28/2023 11:00,R_3gwj2Sc9OZLse3Y,,,,,40.1025,-76.0761,anonymous,EN,Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE,SPORE Kidney Cancer - DF/HCC,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA101942,https://trp.cancer.gov/spores/abstracts/dfhcc_gu.htm,,Kidney Cancer,823948
12/28/2023 11:01,12/28/2023 11:01,IP Address,73.130.95.160,100,27,TRUE,12/28/2023 11:01,R_6MuqQYGy8Gh6cUC,,,,,40.1025,-76.0761,anonymous,EN,Mayo Clinic Hepatobiliary SPORE,SPORE Liver - Mayo Clinic,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA210964,https://trp.cancer.gov/spores/abstracts/mayo_hepatobiliary.htm,,Liver Cancer,869948
12/28/2023 11:02,12/28/2023 11:02,IP Address,73.130.95.160,100,12,TRUE,12/28/2023 11:02,R_3D0XfljdGoDZTe0,,,,,40.1025,-76.0761,anonymous,EN,Specialized Program Of Research Excellence (SPORE) in Leukemia.,SPORE Leukemia - WUSTL,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA171963,https://trp.cancer.gov/spores/abstracts/wustl_leukemia.htm,,Leukemia,148629
12/28/2023 11:03,12/28/2023 11:03,IP Address,73.130.95.160,100,20,TRUE,12/28/2023 11:03,R_5M6OFKMiAAjk6QF,,,,,40.1025,-76.0761,anonymous,EN,SPORE for Translational Approaches to Brain Cancer,SPORE Brain Cancer - Northwestern,SPORE,DCTD,,,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA221747,https://trp.cancer.gov/spores/abstracts/northwestern_brain.htm,,Brain Cancer,376423
12/28/2023 11:03,12/28/2023 11:04,IP Address,73.130.95.160,100,37,TRUE,12/28/2023 11:04,R_3HoEZy2Faeb4Kxo,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Brain Cancer  - The University of Texas MD Anderson Cancer Center ,SPORE Brain Cancer - Texas,SPORE,DCTD,,,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA127001,https://trp.cancer.gov/spores/abstracts/mdanderson_brain.htm,,Brain Cancer,887632
12/28/2023 11:05,12/28/2023 11:05,IP Address,73.130.95.160,100,28,TRUE,12/28/2023 11:06,R_3eLYFH2ly0m8fh7,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Gastrointestinal Cancer - The University of Texas MD Anderson Cancer Center,SPORE Gastrointestinal Cancer - MDA,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA221707,https://trp.cancer.gov/spores/abstracts/mdanderson_gi.htm,,Gastric Cancer,567852
12/28/2023 11:06,12/28/2023 11:07,IP Address,73.130.95.160,100,68,TRUE,12/28/2023 11:07,R_7YlUqCWR4sO0Zr9,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Leukemia  - The University of Texas MD Anderson Cancer Center ,SPORE Leukemia - Texas,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA100632,https://trp.cancer.gov/spores/abstracts/mdanderson_leukemia.htm,,Leukemia,797976
12/28/2023 11:08,12/28/2023 11:09,IP Address,73.130.95.160,100,17,TRUE,12/28/2023 11:09,R_1Ta5LATPtcUFEuB,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Lung Cancer - Fred Hutchinson Cancer Research Center ,SPORE in Lung Cancer - Fred Hutch,SPORE,DCTD,"HOUGHTON, A MCGARRY",,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA228944,https://trp.cancer.gov/spores/abstracts/fhcrc_lung.htm,,Lung Cancer,581522
12/28/2023 11:10,12/28/2023 11:10,IP Address,73.130.95.160,100,9,TRUE,12/28/2023 11:10,R_54eDxN23wAPu9cR,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Lung Cancer - Yale,SPORE in Lung Cancer - Yale,SPORE,DCTD,"HERBST, ROY S",,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA196530,https://trp.cancer.gov/spores/abstracts/yale_lung.htm,,Lung Cancer,862867
12/28/2023 11:11,12/28/2023 11:11,IP Address,73.130.95.160,100,5,TRUE,12/28/2023 11:11,R_5qg8rzt2VmcWJGB,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Myeloid Malignancies,SPORE in Myeloid Malignancies,SPORE,DCTD,"EBERT, BENJAMIN LEVINE",,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA206963,https://trp.cancer.gov/spores/abstracts/brigham_and_women_leukemia.htm,,"Leukemia,Multiple Myeloma",351524
12/28/2023 11:11,12/28/2023 11:11,IP Address,73.130.95.160,100,16,TRUE,12/28/2023 11:11,R_1Yi7tZjw3Bwdhxw,,,,,40.1025,-76.0761,anonymous,EN,ADMIRAL Study: Admixture analysis of acute lymphoblastic leukemia in African American children,ADMIRAL,"Pediatric/AYA,Health Disparities",DCCPS,Logan Spector Ph.D.,spect012@umn.edu,Danielle L. Daee Ph.D. ,danielle.daee@nih.gov,,R01CA239701,https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=9995648&term=CA239701,,Leukemia,571518
12/28/2023 11:12,12/28/2023 11:13,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 11:13,R_6JdDDlPzSshMP6N,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Gastrointestinal Cancer -Vanderbilt-Ingram Cancer Center,SPORE in Gastrointestinal Cancer - Vanderbilt,SPORE,DCTD,"COFFEY, ROBERT J",,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA236733,https://trp.cancer.gov/spores/abstracts/vanderbilt_gi.htm,,Gastric Cancer,214884
12/28/2023 11:13,12/28/2023 11:17,IP Address,73.130.95.160,100,224,TRUE,12/28/2023 11:17,R_32W88ZGjquw3A8w,,,,,40.1025,-76.0761,anonymous,EN,Brain Tumor SPORE Grant,SPORE in Brain Cancer - UCSF,SPORE,DCTD,"BERGER, MITCHEL S",,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA097257,https://trp.cancer.gov/spores/abstracts/ucsf_brain.htm,,Brain Cancer,974215
12/28/2023 11:17,12/28/2023 11:18,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 11:18,R_5D1spRB6xYrjODp,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Hepatocellular Carcinoma - The University of Texas MD Anderson Cancer Center ,SPORE in Hepatocellular Carcinoma,SPORE,DCTD,"BERETTA, LAURA ",,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA217674,https://trp.cancer.gov/spores/abstracts/mdanderson_hepatobiliary.htm,,Liver Cancer,453824
12/28/2023 11:18,12/28/2023 11:19,IP Address,73.130.95.160,100,48,TRUE,12/28/2023 11:19,R_3EcZbPg2sDXs1mt,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Leukemia- The Memorial Sloan Kettering Cancer Center ,SPORE in Leukemia - MSK,SPORE,DCTD,"ABDEL-WAHAB, OMAR ",,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA254838,https://trp.cancer.gov/spores/abstracts/mskcc_leukemia.htm,,Leukemia,895984
12/28/2023 11:19,12/28/2023 11:19,IP Address,73.130.95.160,100,5,TRUE,12/28/2023 11:19,R_338nqVzEM4U7PqW,,,,,40.1025,-76.0761,anonymous,EN,SPORE: Targeted Therapies for Glioma,SPORE: Targeted Therapies for Glioma,SPORE,DCTD,"BATCHELOR, TRACY T",,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA165962,https://trp.cancer.gov/spores/abstracts/brigham_and_women_brain.htm,,Brain Cancer,468366
12/28/2023 11:20,12/28/2023 11:20,IP Address,73.130.95.160,100,4,TRUE,12/28/2023 11:20,R_33v5oFuq82kK3aY,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Bladder Cancer,SPORE in Bladder Cancer,SPORE,DCTD,"BAJORIN, DEAN F",,"Arnold, Julia T",jarnold@mail.nih.gov,,P50CA221745,https://trp.cancer.gov/spores/abstracts/mskcc_bladder.htm,,Bladder Cancer,488472
12/28/2023 11:27,12/28/2023 11:27,IP Address,73.130.95.160,100,34,TRUE,12/28/2023 11:27,R_13gy2eFwlQ5x5Jg,,,,,40.1025,-76.0761,anonymous,EN,Barrett’s Esophagus Translational Research Network (BETRNet),BETRNet,,DCP,,,"RICHMOND, ELLEN S.; YASSIN, RIHAB R.",er115z@nih.gov,RFA-CA-16-007; RFA-CA-16-006; RFA-CA-10-014,,https://prevention.cancer.gov/major-programs/barretts-esophagus-translational-research-network-betrnet,https://www.vumc.org/cqs/statistical-data-centers,Esophageal Cancer,855838
12/28/2023 11:28,12/28/2023 11:28,IP Address,73.130.95.160,100,7,TRUE,12/28/2023 11:28,R_5I6sFgkwU1755hr,,,,,40.1025,-76.0761,anonymous,EN,Cellular Cancer Biology Imaging Research,CCBIR,,DCB,"PROVENZANO, PAOLO; BACKMAN, VADIM; WIRTZ, DENIS; DANUSER, GAUDENZ",pprovenz@umn.edu; v-backman@northwestern.edu; WIRTZ@JHU.EDU; gaudenz.danuser@utsouthwestern.edu,"BECKER, STEVEN",beckersteven@mail.nih.gov,RFA-CA-21-002,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/ccbir,https://www.cancercomplexity.synapse.org/,This program focuses on cancer broadly - not limited to a primary cancer type,894349
12/28/2023 11:41,12/28/2023 11:55,IP Address,73.130.95.160,100,861,TRUE,12/28/2023 11:55,R_1iEaaT1a8lkfmj9,,,,,40.1025,-76.0761,anonymous,EN,Population-based Research to Optimize the Screening Process,PROSPR,,DCCPS,"LI, CHRISTOPHER I",cili@fredhutch.org,"TUOVINEN, PRIYANGA",tuovinenhr@mail.nih.gov,CA16-017;RFA-CA-16-016,,https://healthcaredelivery.cancer.gov/prospr/,https://healthcaredelivery.cancer.gov/prospr/datashare/,"Cervical Cancer,Colorectal Cancer,Lung Cancer",979823
12/28/2023 12:48,12/28/2023 13:02,IP Address,73.130.95.160,100,894,TRUE,12/28/2023 13:02,R_33f9kL0xWdnu3WX,,,,,40.1025,-76.0761,anonymous,EN,Consortium on Translational Research in Early Detection of Liver Cancer,TLC,,DCP,,,"RINAUDO, JO ANN S.",rinaudoj@mail.nih.gov,RFA-CA-22-031;RFA-CA-22-032;RFA-CA-17-025;RFA-CA-17-028,,https://prevention.cancer.gov/major-programs/translational-liver-cancer-tlc-consortium,,Liver Cancer,657125
12/28/2023 13:03,12/28/2023 13:15,IP Address,73.130.95.160,100,776,TRUE,12/28/2023 13:15,R_3mDkNfVykV0JfOW,,,,,40.1025,-76.0761,anonymous,EN,Connect for Cancer Prevention Study,Connect,,DCEG,,,Mia M. Gaudet,mia.gaudet@nih.gov,,,https://dceg.cancer.gov/research/who-we-study/cohorts/connect,https://github.com/episphere/connect/wiki,This program focuses on cancer broadly - not limited to a primary cancer type,212150
12/28/2023 14:10,12/28/2023 14:29,IP Address,73.130.95.160,100,1114,TRUE,12/28/2023 14:29,R_7Ugb0CPBJJj7JE1,,,,,40.1025,-76.0761,anonymous,EN,My Pediatric and Adult Rare Tumor Network,MyPART,Pediatric/AYA,CCR,,,"Karlyne M. Reilly, Ph.D.",karlyne.reilly@nih.gov,,,https://www.cancer.gov/pediatric-adult-rare-tumor/,,This program focuses on cancer broadly - not limited to a primary cancer type,759169
12/28/2023 14:32,12/28/2023 14:34,IP Address,73.130.95.160,100,100,TRUE,12/28/2023 14:34,R_6f8rVzzDKa5aTJ4,,,,,40.1025,-76.0761,anonymous,EN,National Childhood Cancer Registry,NCCR,Pediatric/AYA,DCCPS,,,Johanna Goderre Jones,johanna.goderrejones@nih.gov,,,https://nccrexplorer.ccdi.cancer.gov/nccr.html,https://nccrexplorer.ccdi.cancer.gov/data-products.html,This program focuses on cancer broadly - not limited to a primary cancer type,569319
12/29/2023 7:01,12/29/2023 7:05,IP Address,73.130.95.160,100,207,TRUE,12/29/2023 7:05,R_1WT4Owcb1JYKZMT,,,,,40.1025,-76.0761,anonymous,EN,The Therapeutically Applicable Research to Generate Effective Treatments,TARGET,Pediatric/AYA,CCG,,,"SMITH, MALCOLM",smithm@ctep.nci.nih.gov,,,https://www.cancer.gov/ccg/research/genome-sequencing/target,https://www.cancer.gov/ccg/,"Brain Cancer,Kidney Cancer,Leukemia,Osteosarcoma",786965
1/4/2024 4:46,1/4/2024 4:52,IP Address,73.130.95.160,100,349,TRUE,1/4/2024 4:52,R_3cdsEdbXqxzjL2V,,,,,40.1025,-76.0761,anonymous,EN,ADVANCED DEVELOPMENT OF INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH AND MANAGEMENT,ITCR,,NIH/OD,"Klemm, Juli",,,juli.klemm@nih.gov,PAR15-331;PAR-15-332;PAR15-333;PAR-15-334;RFA-CA-19-040;RFA-CA-20-009;RFA-CA-19-038;RFA-CA-20-007;RFA-CA-19-039;RFA-CA-20-008;RFA-CA-19-041;RFA-CA-20-010;RFA-CA-19-042;RFA-CA-20-060;RFA-CA-21-013;RFA-CA-21-014;RFA-CA-21-015;RFA-CA-21-016;RFA-CA-21-017;RFA-CA-21-018;RFA-CA-21-019;RFA-CA-22-023;RFA-CA-22-021;RFA-CA-22-022;RFA-CA-22-024;RFA-CA-23-014;RFA-CA-23-015;RFA-CA-23-016;RFA-CA-23-017,,https://itcr.cancer.gov/about-itcr,https://itcr.cancer.gov/informatics-tools,This program focuses on cancer broadly - not limited to a primary cancer type,595982
1/4/2024 4:53,1/4/2024 7:07,IP Address,73.130.95.160,100,8036,TRUE,1/4/2024 7:07,R_36BXfM0MtJ901dD,,,,,40.1025,-76.0761,anonymous,EN,All of Us,All of Us,,NIH/OD,,help@joinallofus.org,,,RFA-HG-21-041;NOT-OD-15-159;OTA-17-002;OTA-18-001;OTA-19-002;OTA-19-003;OTA-19-004;OTA-20-001;OTA-20-009;OTA-22-006;OTA23-001;OTA-23-002;OTA-23-003;OT-PM-16-002;OT-PM-16-003;OT-PM-17-002;OT-PM-18-002;OT-PM-18-003;OT-PM-19-001;OT-PM-20-001;RFA-HG-23-018;RFA-LM-21-002;RFA-PM-16-001;RFA-PM-16-002;RFA-PM-16-003;RFA-PM-23-001;RFA-PM-23-002;RFA-RM-21-001;RFA-RM-21-002;RFA-RM-21-003;RFA-RM-21-004;RFA-RM-21-005;RFA-RM-21-006,,https://allofus.nih.gov/,https://www.researchallofus.org/,This program focuses on cancer broadly - not limited to a primary cancer type,757670
1/4/2024 7:08,1/4/2024 7:08,IP Address,73.130.95.160,100,32,TRUE,1/4/2024 7:08,R_1FK9pA9Q6uZjMfz,,,,,40.1025,-76.0761,anonymous,EN,Childhood Cancer Survivor Study,CCSS,Pediatric/AYA,"CIB,CTEP,DCEG","ARMSTRONG, GREGORY; Seibel, Nita",greg.armstrong@stjude.org; seibelnl@mail.nih.gov,"TIMMER, WILLIAM C.",timmerw@mail.nih.gov,RFA-CA-20-052;RFA-CA-15-502,,https://ccss.stjude.org/,https://ccss.stjude.org/public-access-data.html,This program focuses on cancer broadly - not limited to a primary cancer type,524000
1/4/2024 7:09,1/4/2024 7:09,IP Address,73.130.95.160,100,36,TRUE,1/4/2024 7:09,R_1pVFUxYb8bxIFah,,,,,40.1025,-76.0761,anonymous,EN,Clinical Proteomic Tumor Analysis Consortium,CPTAC,Pediatric/AYA,DCTD,,,"HILTKE, TARA",hiltket@mail.nih.gov,RFA-CA-15-023;RFA-CA-15-021;RFA-CA-21-024;RFA-CA-21-023,,https://proteomics.cancer.gov/programs/cptac,"https://gdc.cancer.gov/about-gdc/contributed-genomic-data-cancer-research/clinical-proteomic-tumor-analysis-consortium-cptac#:~:text=The%20National%20Cancer%20Institute%27s%20Clinical,and%20genome%20analysis%2C%20or%20proteogenomics.",This program focuses on cancer broadly - not limited to a primary cancer type,903892
1/4/2024 7:10,1/4/2024 7:10,IP Address,73.130.95.160,100,44,TRUE,1/4/2024 7:11,R_1MipxFHkYEwaHco,,,,,40.1025,-76.0761,anonymous,EN,Partnerships to Advance Cancer Health Equity (PACHE),PACHE,Health Disparities,CRCHD,,,"Rodriguez, Laritza; Wali, Anil; Davani, Behrous ",laritza.rodriguez@nih.gov,PAR-18-767;PAR-22-249;PAR-22-239;PAR-18-911;PAR-18-361,,https://www.cancer.gov/about-nci/organization/crchd/diversity-training/pache,,This program focuses on cancer broadly - not limited to a primary cancer type,899007
1/4/2024 7:11,1/4/2024 7:12,IP Address,73.130.95.160,100,47,TRUE,1/4/2024 7:12,R_5jePwPV2iDqqEUE,,,,,40.1025,-76.0761,anonymous,EN,CTD^2: Cancer Target Discovery and Development,CTD^2,Pediatric/AYA,CCG,,,"Komschlies Mcconvill, Kristin",ocg@mail.nih.gov,RFA-CA-16-014;PAR-21-274,,https://www.cancer.gov/ccg/research/functional-genomics/ctd2,https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal,This program focuses on cancer broadly - not limited to a primary cancer type,996219
2/23/2024 12:59,2/23/2024 13:03,IP Address,73.130.95.160,100,276,TRUE,2/23/2024 13:03,R_1nPJ8vT2ixNG5le,,,,,40.1025,-76.0761,anonymous,EN,Childhood Cancer Data Initiative,CCDI,Pediatric/AYA,"CCG,DCB,DCCPS,DCEG,DCP,DCTD,OCC,CBIIT,CCT,RPG","Allen, Greg;Alonzo, Todd;Armstrong, Gregory;Ashworth, Alan;Boi, Shannon;Brown, Michael;Budd, Kaitlin;Chuang, Jeffrey Hsu-Min;Curington, Christina;Dela Cruz, Filemon S;Dmitrovsky, Ethan;Doherty, Jennifer;Druker, Brian J;Dyer, Michael A;Erin Marcotte;Eve Shalley;Evers, Bernard Mark;Fearon, Eric R.;Foster, Jessica;Francis, Connor;Freedman, Leonard;Gabriel, Stacey;Glimcher, Laurie Hollis;Gorlick, Richard G;Griffith, Obi L;Grosshans, David;Guergana Savova;Hernandez, Brenda;Heslop, Helen E;Hoang, Bang;Hoang, Bang ;Houghton, Peter J;Jason Yustein;Jeffrey Olson;Jensen, Roy A.;Johnson, Candace S.;Kevin Jones;Kimberly Stegmaier;Kohler, Betsy;Krause, Diane S;Lake, Joe;Lerman, Caryn;Levy, Shawn;Li, Xiaonan;Limoli, Charles;Lipkin, Joel;Liu, Tao;Lock, Richard B;Lupien, Leslie;Mackall, Crystal;Marth, Gabor T;Meliha Yetisgen;Mesa, Ruben A;Meshinchi, Soheil;Metelitsa, Leonid;Moon, Grace;Mosse, Yael P;Ngen, Ethel;Nichols, Kim Erika;Okimoto, Ross;Onar-Thomas, Arzu;Plotkin, Scott;Pollock, Brad H.;Pollock, Raphael E.;Ramirez Milan, Nilsa Del Carmen;Richard Vile;Robert Kortum;Roberts, Charles;Roy, Souvik;Rustgi, Anil K;Samuel Volchenboum;Spector, Logan G.;Tamara Porter Miller;Teachey, David;Thomas Blick Alexander;Thompson, Craig;Todd A. Alonzo;Tucker, Thomas;Ulrich, Cornelia M.;Van Allen, Eliezer M;Vile, RIchard;Vonderheide, Robert H;Wagner, Lynne;Weigel, Brenda;Weissmiller, April;Wenyong Chen;Wiggins, Charles;Wu, Xiao-Cheng;Ronai, Ze'ev A;Cowan, Kenneth H;Ramalingam, Suresh S;Palucka, Anna Karolina",Alan.Ashworth@ucsf.edu;anil2@mail.med.upenn.edu;arzu.onar@stjude.org;aweissmiller@yahoo.com;bahoang@montefiore.org;bpollock@ucdavis.edu;candace.johnson@roswellpark.org;charles.roberts@stjude.org;clerman@usc.edu;climoli@uci.edu;cmackall@stanford.edu;connor.francis@ufl.edu;dgrossha@mdanderson.org;diane.krause@yale.edu;drukerb@ohsu.edu;eliezerm_vanallen@dfci.harvard.edu;engen1@jhmi.edu;eshalley@essexmanagement.com;fd2177@columbia.edu;fearon@umich.edu;fosterjb@chop.edu;gmarth@genetics.utah.edu;Greg.Allen@ucsf.edu;greg.armstrong@stjude.org;Guergana.Savova@childrens.harvard.edu;hheslop@bcm.edu;houghtonp@uthscsa.edu;jason.yustein@emory.edu;jeff.chuang@jax.org;jlipkin@4points.com;JOlson@emory.edu;kaitlin.budd@stjude.org;;kevin.jones@hci.utah.edu;Kimberly_Stegmaier@dfci.harvard.edu;laurie_glimcher@dfci.harvard.edu;leslie_lupien@dfci.harvard.edu;lsmeteli@txch.org;marcotte@umn.edu;mark.evers@uky.edu;mcb52@duke.edu;;melihay@uw.edu;mesar@uthscsa.edu;Michael.Dyer@stjude.com;MICHAEL.DYER@STJUDE.ORG;mosse@chop.edu;neli.ulrich@hci.utah.edu;nicholsk@email.chop.edu;nilsa.ramirez@nationwidechildrens.org;obigriffith@wustl.edu;peter.odwyer@uphs.upenn.edu;raphael.pollock@osumc.edu;rgorlick@mdanderson.org;rhv@upenn.edu;rjensen@kumc.edu;rlock@ccia.unsw.edu.au;robert.kortum@usuhs.edu;ross.okimoto@ucsf.edu;shannon.boi@stjude.org;slevy@hudsonalpha.org;slv@uchicago.edu;smeshinc@fredhutch.org;souvik.roy@uta.edu;spector@umn.edu;splotkin@mgh.harvard.edu;stacey@broad.mit.edu;talex@email.unc.edu;talonzo@childrensocologygroup.org;talonzo@childrensoncologygroup.org;tamara.miller@emory.edu;teacheyd@email.chop.edu;thompsonc@mskcc.org;TLiu@ccia.unsw.edu.au;vile.richard@mayo.edu;wechen@coh.org;weige007@umn.edu;xiaonan.li@northwestern.edu;ronai@sbpdiscovery.org;kcowan@unmc.edu;ssramal@emory.edu;karolina.palucka@jax.org,"Li, Jerry;Guan, Ping;Jhappan, Chamelli;Lee, Cecilia H.;Ptak, Krzysztof;Bakos, Alexis Diane;Belin, Precilla L.;Bian, Yansong;Bourcier, Katarzyna;Coulombe, James N.;Daee, Danielle L.;Damico, Mark W.;Elijanne, Mariam;Garson, Amy;Gayle, Sylvia;He, Min;Jakowlew, Sonia;Joseph Kofi Agyin;Klauzinska, Malgorzata;Komschelies, Kristin;Kondapaka, Sudhir;Lam, Clara;Lim, Susan;Lisa M. Gallicchio;Lubensky, Irina;Maas, Stefan;Margaret M. Mooney;Mietz, Judy;Miguel Ossandon;Miller, David J.;Mooney, Margaret M.;Morgan O'Hayre;Prasanna, Pat;Roberson, Sonya;Rotunno, Melissa;Schmidt, Michael;Shafik, Hasnaa;Smith, Malcolm M.;Subhashini Jagu;Sudhir B. Kondapaka;Tatalovich, Zaria;TImmer, William C.;Weber, Michael Nicholas N.;Yansong Bian;Yansong, Bian;Zhang-Zhi Hu",alexis.bakos@nih.gov;belinpl@mail.nih.gov;bourcierkd@mail.nih.gov;cecilia.lee@nih.gov;Clara.Lam@nih.gov;coulombej@mail.nih.gov;daeed@mail.nih.gov;damicomw@mail.nih.gov;danielle.daee@nih.gov;david.miller3@nih.gov;eljannem@mail.nih.gov;garsona@mail.nih.gov;hem3@mail.nih.gov;huzhuang@mail.nih.gov;jakowles@mail.nih.gov;jerry.li@nih.gov;jhappanc@mail.nih.gov;joseph.agyin@nih.gov;katarzyna.bourcier@nih.gov;klauzing@mail.nih.gov;komschkr@mail.nih.gov;kondapas@mail.nih.gov;krzysztofptak@ninds.nih.gov;lims@mail.nih.gov;lisa.gallicchio@nih.gov;lubenskyi@mail.nih.gov;maassw@mail.nih.gov;mietzj@mail.nih.gov;mooneym@mail.nih.gov;mschmidt@mail.nih.gov;Nick.Weber@nih.gov;ohayrem@mail.nih.gov;ossandom@mail.nih.gov;patajeprasanna@mail.nih.gov;ping.guan@nih.gov;robersos@mail.nih.gov;rotunnom@mail.nih.gov;shafikh@mail.nih.gov;sk313a@nih.gov;smithm@ctep.nci.nih.gov;sylvia.gayle@nih.gov;tatalovichzp@mail.nih.gov;william.timmer@nih.gov;yansong.bian@nih.gov,,3UG1CA189828-07S1;3UG1CA189828-08S2;3U24CA055727-26S1;2UM1CA081457-21;5UM1CA228823-03;5UM1CA081457-22;7UM1CA228823-04S1;3P30CA082103-21S9;3P30CA168524-09S3;P30CA069533-22S5;P30CA125123-14S6;P30CA008748-54S3;P30CA016520-44S5;P30CA014089-45S6;P30CA054174-25S2;P30CA046592-31S8;P30CA021765-41S3;P30CA006516-55S7;3P30CA016058-44S3;3P30CA046592-31S4;3P30CA042014-31S5;3P30CA013696-45S1;3P30CA082103-21S6;3P30CA054174-25S1;3P30CA016520-44S6;3P30CA016056-43S5;3P30CA177558-08S2;3R21CA242933-02S1;3U24CA237719-02S1;3R21CA242861-02S1;3U24CA209999-05S1;3UG1CA189955-07S1;3UG1CA189955-08S1;PUR316201200124W*1PUR261201300028I*2REQ5790900*2;75N91020F00125-0-0-1;75N91020F00003;600.300.20.01;75N91019D00024-0-759102000021-0;1U24CA263963-01;1U24CA263963-02;1U24CA263963-03;1U24CA263963-04;1U24CA263963-05;1U01CA263967-01;1U01CA263967-03;26115003B91020F00001;261201400004I;HHSN261201800007I;HHSN261201800011I;HHSN261201800016I;HHSN261201800032I;HHSN261201800014I;HHSN261201800013I;3U24HD090743-06S2;3U24HD090744-06S1;K08CA263179-01;K12CA090354-21;K99CA263021-01;F31CA265285-01;1F30CA260911-01;1F32CA261034-01;1K08CA259610-01;K08CA263179-02;K12CA090354-22;K99CA263021-02;F31CA265285-02;1F30CA260911-02;5F32CA261034-02;1K08CA259610-02;K08CA263179-03;K12CA090354-23;F31CA265285-03;1F30CA260911-03;F32CA261034-03;1K08CA259610-03;5U10CA180899-08;5U24CA196173-07;3U10CA180899-08S1;1R01CA262887-01;1OT2OD027852-01;1R03CA256550-01;1R21CA262994-01;1R15CA263868-01;3P30CA008748-55S3;2U01CA199288-07;1U01CA263981-02;5U01CA199000-07;U01CA199221-08;3U01CA249245-01A1;3U01CA248226-02;3U24CA248010-02;3R21CA258242-01;3U54CA231637-01W1;3U54CA231652-01W1;3U10CA180899-09S2;1R01CA266105-01;5R21CA262994-02;3K07CA211956-05W1;R37CA255453;600000;26116004B91020F00003-0-0-1;PUR6794296*1;PUR6794300*1;PUR6807932*1;1R03CA251976-01A1;1R21CA263223-01A1;1R21CA267914-01;1R21CA259926-01A1;1R21CA267515-01;1R21CA267365-01;1R01CA239701-01A1;1R01CA241452-01A1;1R01CA222518-01A1;APC20005001-1-0-1;PUR6456092*2;K12CA076930-21;1F32CA250155-01A1;1U01CA269420-01;261201400004I-0-759102000001-1;75N91019D00024-0-759102100013-1;1U01CA263967-02;2U01CA199000-06;2U01CA199221-07;2U01CA199288-06;1U01CA263981-01;1R37CA255453-01A1;1R01CA255643-01A1;3U24HD090744-05S1;75N91020F00035;600.035.2;1U01CA263969-01;1U01CA263957-01;PUR6159453*16159453ACO20029-001-00000;PUR6512769*1;276130;1R01CA263500-01;1R01CA255596-01A1;1R01CA262012-01;1R01CA262250-01;1R01CA254892-01A1;HHSN261201400004I/75N91020F00001;75N91020F00003;600.300.21.01;3P30CA030199-42S1;3P30CA036727-37S5;3P30CA138292-14S2;3P30CA014089-47S1;3P30CA016520-47S3;3P30CA021765-44S4;3P30CA006516-58S4;3P30CA034196-37S1,https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative,https://ccdi.cancer.gov/home,This program focuses on cancer broadly - not limited to a primary cancer type,708951
3/12/2024 9:52,3/12/2024 9:52,IP Address,128.231.234.3,100,9,TRUE,3/12/2024 9:52,R_5qmQbnWrXG62OXj,,,,,39.0462,-77.1195,anonymous,EN,Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS),ACCSIS,Cancer Moonshot,DCCPS,,,"GRIMES, GENEVIEVE M",medleyge@mail.nih.gov,CA17-039;CA-17-038;CA-19-018,,https://healthcaredelivery.cancer.gov/accsis/,https://accsis.rti.org/consortium/cc/,Colorectal Cancer,813977
3/12/2024 9:53,3/12/2024 9:53,IP Address,128.231.234.3,100,7,TRUE,3/12/2024 9:53,R_7CZz8Zy6NPQ508G,,,,,39.0462,-77.1195,anonymous,EN,Acquired Resistance to Therapy Network,ARTNet,Cancer Moonshot,DCTD,,,"hildesheim, jeff",hildesheimj@mail.nih.gov,RFA-CA-21-052;RFA-CA-21-053,,https://www.nciartnet.org/en/,https://www.nciartnet.org/en/resources/data-sharing-catalog/,This program focuses on cancer broadly - not limited to a primary cancer type,572465
3/12/2024 9:53,3/12/2024 9:53,IP Address,128.231.234.3,100,6,TRUE,3/12/2024 9:53,R_1tEhRTZIvykYvSu,,,,,39.0462,-77.1195,anonymous,EN,Development and Expansion of Digital Tools to Support Smoking Cessation,C3I,Cancer Moonshot,DCCPS,,,"Vandor, Stacey",vandors@mail.nih.gov,,26114002B91019F00132-0-0-1,https://cancercontrol.cancer.gov/brp/tcrb/cancer-center-cessation-initiative,,This program focuses on cancer broadly - not limited to a primary cancer type,203273
3/12/2024 9:54,3/12/2024 9:54,IP Address,128.231.234.3,100,6,TRUE,3/12/2024 9:54,R_2q2GqtpgSi9vnQl,,,,,39.0462,-77.1195,anonymous,EN,Cancer Immunologic Data Commons,CIDC,Cancer Moonshot,DCTD,"CERAMI, ETHAN",cerami@jimmy.harvard.edu,"THURIN, MAGDALENA",thurinm@mail.nih.gov,RFA-CA-17-006; RFA-CA-22-038,,https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.html,,This program focuses on cancer broadly - not limited to a primary cancer type,878293
3/12/2024 9:54,3/12/2024 9:54,IP Address,128.231.234.3,100,5,TRUE,3/12/2024 9:54,R_7EsUcGG2Id4fyHx,,,,,39.0462,-77.1195,anonymous,EN,CANCER IMMUNE MONITORING AND ANALYSIS CENTERS,CIMAC,Cancer Moonshot,"CTEP,DCTD",,,"Thurin, Magdalena",thurinm@mail.nih.gov,RFA-CA-17-005;RFA-CA-22-038,,https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,722497
3/12/2024 9:54,3/12/2024 9:54,IP Address,128.231.234.3,100,5,TRUE,3/12/2024 9:54,R_1hAtEVJQxdDAJwW,,,,,39.0462,-77.1195,anonymous,EN,Co-Clinical Imaging Research Resource Program,CIRP,Cancer Moonshot,DCTD,,,"ZHANG, HUIMING",zhanghui@mail.nih.gov,PAR-18-841;PAR-16-385;PAR-15-266,,https://ncihub.cancer.gov/groups/cirphub/overview,,This program focuses on cancer broadly - not limited to a primary cancer type,785242
3/12/2024 9:55,3/12/2024 9:55,IP Address,128.231.234.3,100,5,TRUE,3/12/2024 9:55,R_21WOJ8cUyhTNfmO,,,,,39.0462,-77.1195,anonymous,EN,Fusion Oncoproteins in Childhood Cancers (FusOnc2),FusOnc2,"Pediatric/AYA,Cancer Moonshot",DCB,"Keren Witkin, Ph.D.",witkinkeren@mail.nih.gov,"Smith,Malcolm",Malcolm.Smith@nih.gov,RFA-CA-17-049;RFA-CA-19-016,,https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/childhood-cancer-research#fusion-oncoproteins-in-childhood-cancers-fusonc2-consortium,,This program focuses on cancer broadly - not limited to a primary cancer type,694024
3/12/2024 9:55,3/12/2024 9:55,IP Address,128.231.234.3,100,5,TRUE,3/12/2024 9:55,R_72JCdz7GfJWhB5x,,,,,39.0462,-77.1195,anonymous,EN,Human Tumor Atlas Network ,HTAN ,"Pediatric/AYA,Cancer Moonshot",DCP,,,"Shannon Hughes, Ph.D.",Shannon.Hughes@nih.gov,RFA-CA-17-036;RFA-CA-17-034;RFA-CA-17-035;RFA-CA-20-042;RFA-CA-21-037,,https://humantumoratlas.org/,https://humantumoratlas.org/explore,This program focuses on cancer broadly - not limited to a primary cancer type,780742
3/12/2024 9:56,3/12/2024 9:56,IP Address,128.231.234.3,100,4,TRUE,3/12/2024 9:56,R_5scDURgIkECkbQP,,,,,39.0462,-77.1195,anonymous,EN,Improving Management of Symptoms Across Cancer Treatments,IMPACT,Cancer Moonshot,DCCPS,,,"ADAMS, LYNN S",lynn.adams@nih.gov,CA17-043;CA-17-042,,https://impactconsortium.rti.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,748258
3/12/2024 9:56,3/12/2024 9:56,IP Address,128.231.234.3,100,5,TRUE,3/12/2024 9:56,R_7YbclIU5HH0eQlH,,,,,39.0462,-77.1195,anonymous,EN,Immuno-Oncology Translation Network,IOTN,Cancer Moonshot,DCB,,,,,RFA-CA-19-012;RFA-CA-19-013;RFA-CA-19-014;RFA-CA-19-015;RFA-CA-17-045;RFA-CA-17-046;RFA-CA-17-047;RFA-CA-17-048;,,https://www.iotnmoonshot.org/en/,https://www.iotnmoonshot.org/en/resources/data-sharing-catalog/,This program focuses on cancer broadly - not limited to a primary cancer type,813392
3/12/2024 9:57,3/12/2024 9:57,IP Address,128.231.234.3,100,4,TRUE,3/12/2024 9:57,R_7QFwyxDqvwRYe2S,,,,,39.0462,-77.1195,anonymous,EN,Implementation Science Centers in Cancer Control ,ISC3,Cancer Moonshot,DCCPS,,,"VINSON, CYNTHIA",cynthia.vinson@nih.gov,RFA-CA-19-005;RFA-CA-19-006,,https://iscentersincancercontrol.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,604098
3/12/2024 9:57,3/12/2024 9:58,IP Address,128.231.234.3,100,10,TRUE,3/12/2024 9:58,R_7j1lWd9vDwTWB1e,,,,,39.0462,-77.1195,anonymous,EN,Oncology Models Forum (U24),OMF,Cancer Moonshot,DCB,"BUTTE, ATUL J",atul.butte@ucsf.edu,Joanna Watson,watsonjo@mail.nih.gov,PAR14-239; PAR-16-059; PAR-17-245; PAR-20-131,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf,https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf#nci-and-omf-resources-related-to-oncology-models,This program focuses on cancer broadly - not limited to a primary cancer type,710880
3/12/2024 9:58,3/12/2024 9:58,IP Address,128.231.234.3,100,6,TRUE,3/12/2024 9:58,R_2MNYtbijP7V7ZMR,,,,,39.0462,-77.1195,anonymous,EN,Pancreatic Cancer Microenvironment Network,PaCMEN,Cancer Moonshot,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,RFA-CA-17-015; RFA-CA-17-016,,https://pacmen.org/,https://pacmen.org/Dbs.html,Pancreas Cancer,970599
3/12/2024 9:59,3/12/2024 9:59,IP Address,128.231.234.3,100,9,TRUE,3/12/2024 9:59,R_7HN2T1LuZCgAlIB,,,,,39.0462,-77.1195,anonymous,EN,Pancreatic Cancer Detection Consortium,PCDC,Cancer Moonshot,DCP,,,"UJHAZY, PETER",ujhazyp@mail.nih.gov,CA-17-015;CA-17-016,,https://prevention.cancer.gov/major-programs/pancreatic-cancer-detection-consortium-pcdc,https://prevention.cancer.gov/major-programs/pancreatic-cancer-detection-consortium-pcdc/pcdc-resources-and-collaborative-opportunities,Pancreas Cancer,147792
3/12/2024 9:59,3/12/2024 9:59,IP Address,128.231.234.3,100,5,TRUE,3/12/2024 9:59,R_2TsiHKGhji61P5D,,,,,39.0462,-77.1195,anonymous,EN,Patient-Derived Xenograft (PDX) Development and Trial Centers Research Network,PDXNet,Cancer Moonshot,DCTD,,,"MOSCOW, JEFFREY ARNOLD",jeffrey.moscow@nih.gov,RFA-CA-17-003;RFA-CA-17-004;RFA-CA-22-012;RFA-CA-22-013,,https://www.pdxnetwork.org/,https://www.pdxnetwork.org/pdccc,This program focuses on cancer broadly - not limited to a primary cancer type,354015
3/12/2024 10:00,3/12/2024 10:00,IP Address,128.231.234.3,100,6,TRUE,3/12/2024 10:00,R_2LYrIlD3f635XcB,,,,,39.0462,-77.1195,anonymous,EN,Participant Engagement and Cancer Genome Sequencing,PE-CGS,Cancer Moonshot,DCCPS,,,"CHOU, WEN-YING",chouws@mail.nih.gov,CA19-046;CA19-045;,,https://pe-cgs.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,158359
3/12/2024 10:00,3/12/2024 10:01,IP Address,128.231.234.3,100,6,TRUE,3/12/2024 10:01,R_7Evc3khREHoEhGh,,,,,39.0462,-77.1195,anonymous,EN,Pediatric Early Phase Clinical Trials Network,PEP-CTN,"Pediatric/AYA,Cancer Moonshot",DCTD,,,Malcolm A. Smith,Malcolm.Smith@nih.gov,RFA-CA-12-502;RFA-CA-17-027;RFA-CA-24-007,,https://ctep.cancer.gov/initiativesPrograms/pep-ctn.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,392293
3/12/2024 10:01,3/12/2024 10:01,IP Address,128.231.234.3,100,6,TRUE,3/12/2024 10:01,R_2MuVt8TDXtibICR,,,,,39.0462,-77.1195,anonymous,EN,Pediatric Preclinical in Vivo Testing (PIVOT) ,PIVOT,"Pediatric/AYA,Cancer Moonshot","CIB,CTEP,DCTD","BULT, CAROL J",carol.bult@jax.org,"Smith, Malcolm ",Malcolm.Smith@nih.gov,RFA-CA-20-034; RFA-CA-14-018; RFA-CA-20-041,,https://preclinicalpivot.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,933551
8/30/2024 7:56,8/30/2024 9:54,IP Address,128.231.234.23,100,7085,TRUE,8/30/2024 9:54,R_1neYCnQNHEZcKpJ,,,,,39.0462,-77.1195,anonymous,EN,NCI’s National Clinical Trials Network,NCTN,,DCTD,,,,,,,https://www.cancer.gov/research/infrastructure/clinical-trials/nctn,https://nctn-data-archive.nci.nih.gov/,This program focuses on cancer broadly - not limited to a primary cancer type,115061
8/30/2024 9:54,8/30/2024 9:58,IP Address,128.231.234.23,100,231,TRUE,8/30/2024 9:58,R_1dXTH6q436oYiro,,,,,39.0462,-77.1195,anonymous,EN,Lung Cancer Master Protocol,Lung-MAP,,DCTD,,,,,,,https://www.cancer.gov/types/lung/research/lung-map,,Lung Cancer,995449
8/30/2024 9:58,8/30/2024 10:06,IP Address,128.231.234.23,100,486,TRUE,8/30/2024 10:06,R_6HundBokieZfFYc,,,,,39.0462,-77.1195,anonymous,EN,MyeloMATCH,MYELOMATCH,,DCTD,,,,,,,https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-07006&r=1,,Leukemia,271172
9/10/2024 7:02,9/10/2024 7:35,IP Address,128.231.234.21,100,1976,TRUE,9/10/2024 7:35,R_70jKluYx36xdyMG,,,,,39.0015,-77.0961,anonymous,EN,NCI-MATCH: Molecular Analysis for Therapy Choice for adults with advanced cancers,NCI-MATCH,,DCTD,,,,,,,https://www.cancer.gov/about-cancer/treatment/clinical-trials/nci-supported/nci-match,https://ecog-acrin.org/clinical-trials/eay131-nci-match-precision-medicine/nci-match-eay131-findings/,This program focuses on cancer broadly - not limited to a primary cancer type,687493
9/10/2024 9:10,9/10/2024 9:10,IP Address,128.231.234.21,100,30,TRUE,9/10/2024 9:10,R_7dpkiPAqJ1HhvWt,,,,,39.0015,-77.0961,anonymous,EN,ComboMATCH Precision Medicine Clinical Trials,ComboMATCH,,DCTD,,,,,,,https://www.cancer.gov/research/infrastructure/clinical-trials/nci-supported/combomatch,,This program focuses on cancer broadly - not limited to a primary cancer type,440678
9/10/2024 9:12,9/10/2024 9:14,IP Address,128.231.234.21,100,121,TRUE,9/10/2024 9:14,R_617rnoUeka1pd10,,,,,39.0015,-77.0961,anonymous,EN,NCI-COG Pediatric MATCH Precision Medicine Clinical Trial,NCI-COG Pediatric MATCH,Pediatric/AYA,DCTD,,,,,,,https://www.cancer.gov/research/infrastructure/clinical-trials/nci-supported/pediatric-match,,This program focuses on cancer broadly - not limited to a primary cancer type,964635
9/10/2024 9:15,9/10/2024 9:29,IP Address,128.231.234.21,100,849,TRUE,9/10/2024 9:29,R_6pxpbiC9k85gPN4,,,,,39.0015,-77.0961,anonymous,EN,Innovative Molecular Analysis Technologies ,IMAT,,CSSI,,,,,RFA-CA-24-008; RFA-CA-24-009; RFA-CA-24-010; RFA-CA-24-011; RFA-CA-23-002; RFA-CA-23-003; RFA-CA-23-004; RFA-CA-23-005; RFA-CA-22-001; RFA-CA-22-002; RFA-CA-22-003; RFA-CA-22-004; RFA-CA-21-003; RFA-CA-21-004; RFA-CA-21-005; RFA-CA-21-006; RFA-CA-20-017; RFA-CA-20-018; RFA-CA-20-019; RFA-CA-20-020; RFA-CA-19-019; RFA-CA-19-020; RFA-CA-19-021; RFA-CA-19-022; RFA-CA-18-002; RFA-CA-18-003; RFA-CA-18-004; RFA-CA-18-005; PAR-18-303; RFA-CA-17-010; RFA-CA-17-011; RFA-CA-17-012; RFA-CA-17-013; RFA-CA-16-001; RFA-CA-16-002; RFA-CA-16-003; RFA-CA-16-004; RFA-CA-15-002; RFA-CA-15-003; RFA-CA-15-004; RFA-CA-15-005; RFA-CA-14-003; RFA-CA-14-004; RFA-CA-14-005; RFA-CA-14-006; RFA-CA-13-001; RFA-CA-13-002; RFA-CA-13-003; RFA-CA-13-004; PAR-13-327; RFA-CA-12-002; RFA-CA-12-003; RFA-CA-12-004; RFA-CA-12-005; RFA-CA-10-003; RFA-CA-10-005; RFA-CA-10-004; RFA-CA-10-001; RFA-CA-10-002; RFA-CA-10-013; RFA-CA-09-006; RFA-CA-09-008; RFA-CA-09-007; RFA-CA-09-004; RFA-CA-09-005; RFA-CA-08-007; RFA-CA-08-006; RFA-CA-08-008; RFA-CA-08-009; RFA-CA-08-010; RFA-CA-08-011; RFA-CA-08-012; RFA-CA-08-013; RFA-CA-08-014; RFA-CA-07-033; RFA-CA-07-035; RFA-CA-07-034; RFA-CA-07-036; RFA-CA-07-037; RFA-CA-07-038; RFA-CA-07-039; RFA-CA-07-040; RFA-CA-07-041; RFA-CA-07-042; RFA-CA-07-043; RFA-CA-07-044; RFA-CA-07-015; RFA-CA-07-017; RFA-CA-07-016; RFA-CA-07-018; RFA-CA-07-022; RFA-CA-07-023; RFA-CA-07-008; RFA-CA-07-009; RFA-CA-07-010; RFA-CA-07-011; RFA-CA-07-006; RFA-CA-07-019; RFA-CA-07-024; RFA-CA-07-001; RFA-CA-07-002; RFA-CA-07-003; RFA-CA-06-002; RFA-CA-06-003; RFA-CA-06-004; RFA-CA-06-005; RFA-CA-06-006; RFA-CA-06-007; RFA-CA-05-002; RFA-CA-05-003; RFA-CA-05-004; RFA-CA-05-006; RFA-CA-05-007; RFA-CA-05-008; PAR-01-104; PAR-01-106; PAR-01-105; PAR-01-107; PAR-99-100; PAR-99-102; PAR-99-101; PAR-99-103; PAR-98-067; PAR-98-066,,https://www.cancer.gov/about-nci/organization/cssi/research/imat,,This program focuses on cancer broadly - not limited to a primary cancer type,270205
9/10/2024 9:29,9/10/2024 9:38,IP Address,128.231.234.21,100,500,TRUE,9/10/2024 9:38,R_1f93xFD7uxTAzin,,,,,39.0015,-77.0961,anonymous,EN,Metastasis Research Network,MetNet,,DCB,,,,,PAR-22-234,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/metnet?cid=eb_govdel#funded-projects,,This program focuses on cancer broadly - not limited to a primary cancer type,826760
9/17/2024 6:04,9/17/2024 6:13,IP Address,73.130.95.160,100,532,TRUE,9/17/2024 6:13,R_1o4iwR3tWXuzRXb,,,,,40.1025,-76.0761,anonymous,EN,Physical Sciences – Oncology Network,PS-ON,,DCB,,,,,,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/pson,https://www.cancercomplexity.synapse.org/,This program focuses on cancer broadly - not limited to a primary cancer type,944494
9/17/2024 6:15,9/17/2024 6:25,IP Address,73.130.95.160,100,554,TRUE,9/17/2024 6:25,R_3DcDxneC4ga2ahU,,,,,40.1025,-76.0761,anonymous,EN,Synthetic Biology and Cancer,SynBio,,CSSI,,,,,RFA-CA-20-054,,https://www.cancer.gov/about-nci/organization/cssi/research/synbio,,This program focuses on cancer broadly - not limited to a primary cancer type,507005
9/17/2024 6:26,9/17/2024 6:31,IP Address,73.130.95.160,100,316,TRUE,9/17/2024 6:31,R_1iVzk6rNfkhZ3PQ,,,,,40.1025,-76.0761,anonymous,EN,Cancer Tissue Engineering Collaborative,TEC,,DCB,,,,,PAR-22-099;PAR-19-113,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec#funded-projects,,This program focuses on cancer broadly - not limited to a primary cancer type,648878
9/17/2024 6:35,9/17/2024 6:45,IP Address,73.130.95.160,100,595,TRUE,9/17/2024 6:45,R_6dJP1ZYAkQSe2xZ,,,,,40.1025,-76.0761,anonymous,EN,The Cancer Genome Atlas Program,TCGA,,,,,,,,,https://www.cancer.gov/ccg/research/genome-sequencing/tcga,https://portal.gdc.cancer.gov/,"Adrenal Gland Cancer,Bile Duct Cancer,Bladder Cancer,Brain Cancer,Breast Cancer,Cervical Cancer,Colorectal Cancer,Esophageal Cancer,Gastric Cancer,Glioblastoma,Head and Neck Cancer,Kidney Cancer,Leukemia,Liver Cancer,Lung Cancer,Melanoma,Mesothelioma,Ovarian Cancer,Pancreas Cancer,Prostate Cancer,Sarcoma,Skin Cancer,Testicular Cancer,Thyroid Cancer,Uterine Cancer",113048
9/17/2024 6:47,9/17/2024 6:48,IP Address,73.130.95.160,100,110,TRUE,9/17/2024 6:48,R_6luDwamhtFJoZoP,,,,,40.1025,-76.0761,anonymous,EN,Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) network,APOLLO,Cancer Moonshot,DCTD,,,,,,,https://proteomics.cancer.gov/programs/apollo-network,https://proteomics.cancer.gov/data-portal,This program focuses on cancer broadly - not limited to a primary cancer type,448544
9/17/2024 6:49,9/17/2024 7:20,IP Address,73.130.95.160,100,1872,TRUE,9/17/2024 7:20,R_61dT2LVNdT7B9cN,,,,,40.1025,-76.0761,anonymous,EN,NCI Telehealth Research Centers of Excellence,TRACE,Cancer Moonshot,DCCPS,,,,,,P50CA271353;P50CA271357;P50CA271358;P50CA271338,https://healthcaredelivery.cancer.gov/telehealth/trace.html,,This program focuses on cancer broadly - not limited to a primary cancer type,427812
9/17/2024 7:20,9/17/2024 7:23,IP Address,73.130.95.160,100,196,TRUE,9/17/2024 7:23,R_3gOyqlBjU3ZUsWs,,,,,40.1025,-76.0761,anonymous,EN,Research on Prostate Cancer in Men of African Ancestry,RESPOND,Cancer Moonshot,"DCCPS,DCEG",,,,,,5U19CA214253,https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=9739310&term=CA214253,,Prostate Cancer,252698
9/17/2024 7:23,9/17/2024 7:39,IP Address,73.130.95.160,100,922,TRUE,9/17/2024 7:39,R_5t0eQ5EcZarrtdc,,,,,40.1025,-76.0761,anonymous,EN,Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes,Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes,Cancer Moonshot,DCCPS,,,,,RFA-CA-17-041;RFA-CA-19-017,,https://cancercontrol.cancer.gov/research-emphasis/contribution-to-the-cancer-moonshot/prevention-and-early-detection#funded,,This program focuses on cancer broadly - not limited to a primary cancer type,867941
9/17/2024 7:39,9/17/2024 7:39,IP Address,73.130.95.160,100,26,TRUE,9/17/2024 7:39,R_6dAf1eLCDr0QxcV,,,,,40.1025,-76.0761,anonymous,EN,Communication and Decision Making for Individuals with Inherited Cancer Syndromes,Communication and Decision Making for Individuals with Inherited Cancer Syndromes,Cancer Moonshot,DCCPS,,,,,RFA-CA-19-001;RFA-CA-20-006,,https://cancercontrol.cancer.gov/research-emphasis/contribution-to-the-cancer-moonshot/prevention-and-early-detection#funded,,This program focuses on cancer broadly - not limited to a primary cancer type,569433
9/17/2024 7:45,9/17/2024 7:46,IP Address,73.130.95.160,100,33,TRUE,9/17/2024 7:46,R_3Y5nLzEiNvleesR,,,,,40.1025,-76.0761,anonymous,EN,"Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors","Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors","Cancer Moonshot,Pediatric/AYA",DCCPS,,,,,RFA-CA-19-033,,https://grants.nih.gov/grants/guide/rfa-files/RFA-ca-19-033.html,,This program focuses on cancer broadly - not limited to a primary cancer type,698865
9/17/2024 7:46,9/17/2024 7:49,IP Address,73.130.95.160,100,207,TRUE,9/17/2024 7:49,R_3sdz9J5KUbxye6p,,,,,40.1025,-76.0761,anonymous,EN,Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care,Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care,Cancer Moonshot,DCCPS,,,,,RFA-CA-19-035,,https://cancercontrol.cancer.gov/research-emphasis/contribution-to-the-cancer-moonshot/optimizing-management-outcomes,,This program focuses on cancer broadly - not limited to a primary cancer type,995602
9/17/2024 7:51,9/17/2024 7:55,IP Address,73.130.95.160,100,206,TRUE,9/17/2024 7:55,R_3oMfyAa8vLmXxrr,,,,,40.1025,-76.0761,anonymous,EN,The Childhood Cancer Data Initiative Molecular Characterization Initiative,MCI,Pediatric/AYA,"CIB,CTEP",,,Malcolm Smith,Malcolm.Smith@nih.gov,,,https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/programs/molecular-characterization,https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002790.v1.p1,"This program focuses on cancer broadly - not limited to a primary cancer type,Brain Cancer,CNS Cancer,Sarcoma",551153
9/17/2024 8:35,9/17/2024 8:42,IP Address,73.130.95.160,100,435,TRUE,9/17/2024 8:42,R_32heMO9BXHiNQXC,,,,,40.1025,-76.0761,anonymous,EN, Pediatric Proton/Photon Consortium Registry,PPCR,Pediatric/AYA,,,,,,,C06CA059267,https://www.pediatricradiationregistry.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,696058
9/17/2024 8:46,9/17/2024 8:49,IP Address,73.130.95.160,100,176,TRUE,9/17/2024 8:49,R_3g09nbdKhGkryKE,,,,,40.1025,-76.0761,anonymous,EN,Modeling Outcomes Using Surveillance Data and Scalable Artificial Intelligence for Cancer,MOSSAIC,,DCCPS,,,,,,,https://computational.cancer.gov/about/mossaic,https://github.com/DOE-NCI-MOSSAIC,This program focuses on cancer broadly - not limited to a primary cancer type,948656
9/17/2024 8:51,9/17/2024 8:51,IP Address,73.130.95.160,100,44,TRUE,9/17/2024 8:51,R_7BtX0d19Xsl8NAW,,,,,40.1025,-76.0761,anonymous,EN,Innovative Methodologies and New Data for Predictive Oncology Model Evaluation,IMPROVE,,,,,,,,,https://computational.cancer.gov/about/improve,https://computational.cancer.gov/view-dataset-finder?f%5B0%5D=dataset_project%3Aimprov,This program focuses on cancer broadly - not limited to a primary cancer type,138931
9/17/2024 8:52,9/17/2024 8:53,IP Address,73.130.95.160,100,68,TRUE,9/17/2024 8:53,R_7eQpffuzrG5L6rk,,,,,40.1025,-76.0761,anonymous,EN,Accelerating Therapeutics for Opportunities in Medicine,ATOM,,,,,,,,,https://computational.cancer.gov/about/atom,https://modac.cancer.gov/,This program focuses on cancer broadly - not limited to a primary cancer type,742505
9/17/2024 8:54,9/17/2024 8:55,IP Address,73.130.95.160,100,58,TRUE,9/17/2024 8:55,R_3zqY8R4Inpqh110,,,,,40.1025,-76.0761,anonymous,EN,PREVENT Cancer Preclinical Drug Development Program,PREVENT,,DCP,,,,,,,https://prevention.cancer.gov/major-programs/prevent-cancer-preclinical-drug-development-program-prevent,https://prevention.cancer.gov/major-programs/prevent-cancer-preclinical-drug-development-program-prevent/available-resources,This program focuses on cancer broadly - not limited to a primary cancer type,753414
9/17/2024 8:55,9/17/2024 8:57,IP Address,73.130.95.160,100,97,TRUE,9/17/2024 8:57,R_503NTzHzreAxsml,,,,,40.1025,-76.0761,anonymous,EN,"The Surveillance, Epidemiology, and End Results (SEER) Program",SEER,,DCCPS,,,,,,,https://seer.cancer.gov/,https://seer.cancer.gov/data-software/,This program focuses on cancer broadly - not limited to a primary cancer type,324570
9/17/2024 8:57,9/17/2024 10:56,IP Address,73.130.95.160,100,7115,TRUE,9/17/2024 10:56,R_3YjJJsGrAgEP9Fn,,,,,40.1025,-76.0761,anonymous,EN,Sub-Saharan African Collaborative HIV and Cancer Consortia,Sub-Saharan African Collaborative HIV and Cancer Consortia,"HIV/AIDS,Health Disparities",OHAM,,,,,RFA-CA-13-010,,https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/research-africa,,This program focuses on cancer broadly - not limited to a primary cancer type,109515
9/17/2024 10:56,9/17/2024 10:57,IP Address,73.130.95.160,100,65,TRUE,9/17/2024 10:57,R_3M5mgtfjzXZv1xe,,,,,40.1025,-76.0761,anonymous,EN,Collaborative Consortia for the Study of HIV-Associated Cancers,Collaborative Consortia for the Study of HIV-Associated Cancers,"HIV/AIDS,Health Disparities",,,,,,RFA-CA-16-018,,https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/research-africa,,This program focuses on cancer broadly - not limited to a primary cancer type,457526
9/17/2024 12:17,9/17/2024 12:20,IP Address,73.130.95.160,100,170,TRUE,9/17/2024 12:20,R_69itJ4juuXYOptD,,,,,40.1025,-76.0761,anonymous,EN,Gabriella Miller Kids First Pediatric Research Program,Kids First,Pediatric/AYA,NIH/OD,,,Marcia Fournier,marcia.fournier@nih.gov,,,https://commonfund.nih.gov/kidsfirst,https://kidsfirstdrc.org/,This program focuses on cancer broadly - not limited to a primary cancer type,483677
9/17/2024 12:22,9/17/2024 12:23,IP Address,73.130.95.160,100,69,TRUE,9/17/2024 12:23,R_5uNwQ4GO6K7leQV,,,,,40.1025,-76.0761,anonymous,EN,Consortium for Cancer Implementation Science,CCIS,Cancer Moonshot,DCCPS,,,,,,,https://cancercontrol.cancer.gov/is/initiatives/ccis,https://cancercontrol.cancer.gov/is/initiatives/ccis/public-goods,This program focuses on cancer broadly - not limited to a primary cancer type,186864
9/17/2024 12:24,9/17/2024 12:29,IP Address,73.130.95.160,100,281,TRUE,9/17/2024 12:29,R_6NhblcWlclLX8Dt,,,,,40.1025,-76.0761,anonymous,EN,Cancer Screening Research Network,CSRN,Cancer Moonshot,DCP,,,,,RFA-CA-23-020;RFA-CA-23-021;RFA-CA-23-022,,https://prevention.cancer.gov/major-programs/cancer-screening-research-network-csrn,,This program focuses on cancer broadly - not limited to a primary cancer type,815645
9/17/2024 12:31,9/17/2024 12:33,IP Address,73.130.95.160,100,113,TRUE,9/17/2024 12:33,R_573Vuw8NbuFxWrk,,,,,40.1025,-76.0761,anonymous,EN,Human Cancer Models Initiative,HCMI,Cancer Moonshot,CCG,,,,,,,https://www.cancer.gov/ccg/research/functional-genomics/hcmi,https://portal.gdc.cancer.gov/projects/HCMI-CMDC,This program focuses on cancer broadly - not limited to a primary cancer type,106416
9/17/2024 12:35,9/17/2024 12:36,IP Address,73.130.95.160,100,28,TRUE,9/17/2024 12:36,R_7DsYciRaFdYqmYx,,,,,40.1025,-76.0761,anonymous,EN,Moonshot Biobank,Moonshot Biobank,Cancer Moonshot,,,,,,,,https://moonshotbiobank.cancer.gov/,https://moonshotbiobank.cancer.gov/,This program focuses on cancer broadly - not limited to a primary cancer type,135183
9/17/2024 12:37,9/17/2024 12:42,IP Address,73.130.95.160,100,290,TRUE,9/17/2024 12:42,R_1R3TnjLmezUBkb3,,,,,40.1025,-76.0761,anonymous,EN,National Cancer Institute's Community Oncology Research Program,NCORP,,DCP,,,,,,,https://ncorp.cancer.gov/,,This program focuses on cancer broadly - not limited to a primary cancer type,934343
9/17/2024 13:59,9/17/2024 14:01,IP Address,174.240.211.77,100,145,TRUE,9/17/2024 14:01,R_1zjQ5ORK2mLCmGD,,,,,40.0558,-75.0773,anonymous,EN,Patient-Derived Models of Cancer,PDMC,Cancer Moonshot,DCB,,,,,PAR-16-344,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/pdmc,https://www.cancer.gov/about-nci/organization/dcb/research-programs/pdmc#nci-supported-resources-related-to-patient-derived-models,This program focuses on cancer broadly - not limited to a primary cancer type,725335
9/17/2024 14:02,9/17/2024 14:07,IP Address,174.240.211.77,100,298,TRUE,9/17/2024 14:07,R_6UgcFgiGJ7B7sps,,,,,40.0558,-75.0773,anonymous,EN,Pediatric Immunotherapy Discovery and Development Network,PI-DDN,"Pediatric/AYA,Cancer Moonshot","CIB,CTEP",,,Judy Mietz,mietzj@mail.nih.gov,RFA-CA-19-004; RFA-CA-17-051; RFA-CA-17-050,,https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/pediatric-immunotherapy-network#the-pediatric-immunotherapy-discovery-and-development-network-pi-ddn,,This program focuses on cancer broadly - not limited to a primary cancer type,594406
9/18/2024 13:11,9/18/2024 13:13,IP Address,128.231.234.21,100,84,TRUE,9/18/2024 13:13,R_70PeFbSPCpPG1AP,,,,,39.0397,-77.1918,anonymous,EN,Duke SPORE in Brain Cancer,SPORE - Brain Cancer - Duke,SPORE,DCTD,,,,,,P50CA190991,https://trp.cancer.gov/spores/abstracts/duke_brain.htm ,,Brain Cancer,936684
9/18/2024 13:13,9/18/2024 13:13,IP Address,128.231.234.21,100,34,TRUE,9/18/2024 13:13,R_31WLzctqYbbBfXX,,,,,39.0397,-77.1918,anonymous,EN,UCLA SPORE in Brain Cancer,SPORE - Brain Cancer - UCLA,SPORE,DCTD,,,,,,P50CA211015,https://trp.cancer.gov/spores/abstracts/ucla_brain.htm  ,,Brain Cancer,862820
9/18/2024 13:14,9/18/2024 13:15,IP Address,128.231.234.21,100,34,TRUE,9/18/2024 13:15,R_3lInBAmD2fLIfaV,,,,,39.0397,-77.1918,anonymous,EN,Translational Research in Breast Cancer,SPORE - Breast Cancer - Baylor,SPORE,DCTD,,,,,,P50CA186784,https://trp.cancer.gov/spores/abstracts/baylor_breast.htm ,,Breast Cancer,223740
9/18/2024 13:15,9/18/2024 13:15,IP Address,128.231.234.21,100,30,TRUE,9/18/2024 13:15,R_5cqNV7LmmhEeBL7,,,,,39.0397,-77.1918,anonymous,EN,Mayo Clinic Breast Cancer SPORE,SPORE - Breast Cancer - Mayo,SPORE,DCTD,,,,,,P50CA116201,https://trp.cancer.gov/spores/abstracts/mayo_breast.htm  ,,Breast Cancer,928773
9/18/2024 13:15,9/18/2024 13:16,IP Address,128.231.234.21,100,38,TRUE,9/18/2024 13:16,R_1s4DQtc5pFj2SNr,,,,,39.0397,-77.1918,anonymous,EN,Hawaii Minority Health and Cancer Disparities SPORE,SPORE - Health Disparities - Hawaii,"SPORE,Health Disparities",DCTD,,,,,,P20CA275734,https://trp.cancer.gov/spores/abstracts/u_hawaii_p20.htm  ,,This program focuses on cancer broadly - not limited to a primary cancer type,223888
9/18/2024 13:16,9/18/2024 13:17,IP Address,128.231.234.21,100,43,TRUE,9/18/2024 13:17,R_7QgWRIGHBpRCOm5,,,,,39.0397,-77.1918,anonymous,EN,Translational Research Program in Colorectal Cancer Disparities,TRPCD,SPORE,DCTD,,,,,,P50CA285275,https://trp.cancer.gov/spores/abstracts/fhcrc_p20.htm  ,,Colorectal Cancer,876460
9/18/2024 13:17,9/18/2024 13:18,IP Address,128.231.234.21,100,36,TRUE,9/18/2024 13:18,R_5PnYuDqgYImtqqJ,,,,,39.0397,-77.1918,anonymous,EN,Liver Cancer Disparities in Alaska Native and American Indian People,SPORE - Liver Cancer,SPORE,DCTD,,,,,,P20CA252732,https://trp.cancer.gov/spores/abstracts/uwashington_p20.htm  ,,Liver Cancer,760700
9/18/2024 13:18,9/18/2024 13:19,IP Address,128.231.234.21,100,42,TRUE,9/18/2024 13:19,R_1Yi7ApDdYL3AuXk,,,,,39.0397,-77.1918,anonymous,EN,Colorado Head and Neck Cancer SPORE,SPORE - Head and Neck Cancer - Colorado,SPORE,DCTD,,,,,,P50CA261605,https://trp.cancer.gov/spores/abstracts/uccc_head-neck.htm  ,,Head and Neck Cancer,825855
9/18/2024 13:19,9/18/2024 13:19,IP Address,128.231.234.21,100,31,TRUE,9/18/2024 13:19,R_7D0NkuCltn7FRBM,,,,,39.0397,-77.1918,anonymous,EN,University of Pittsburgh Head and Neck Cancer SPORE,SPORE - Head and Neck Cancer - Pittsburg,SPORE,DCTD,,,,,,P50CA097190,https://trp.cancer.gov/spores/abstracts/pitt_head-neck.htm  ,,Head and Neck Cancer,840375
9/18/2024 13:19,9/18/2024 13:20,IP Address,128.231.234.21,100,30,TRUE,9/18/2024 13:20,R_3ddmjgvU3eOixzO,,,,,39.0397,-77.1918,anonymous,EN,Head and Neck SPORE at the University of Wisconsin,SPORE - Head and Neck Cancer - Wisconsin,SPORE,DCTD,,,,,,P50DE026787,https://trp.cancer.gov/spores/abstracts/wisconsin_head-neck.htm  ,,Head and Neck Cancer,611383
9/18/2024 13:20,9/18/2024 13:21,IP Address,128.231.234.21,100,29,TRUE,9/18/2024 13:21,R_5WINTrpX4sd97tT,,,,,39.0397,-77.1918,anonymous,EN,Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer,SPORE - Head and Neck Cancer - Yale,SPORE,DCTD,,,,,,P50DE030707,https://trp.cancer.gov/spores/abstracts/yale_head-neck.htm  ,,Head and Neck Cancer,521693
9/18/2024 13:21,9/18/2024 13:23,IP Address,128.231.234.21,100,111,TRUE,9/18/2024 13:23,R_5dQpBHUkDmkxXzh,,,,,39.0397,-77.1918,anonymous,EN,Developmental and Hyperactive Ras Tumor (DHART) SPORE,SPORE - Hyperactive RAS,SPORE,DCTD,,,,,,U54CA196519,https://trp.cancer.gov/spores/abstracts/indiana_hyperactive.htm  ,,This program focuses on cancer broadly - not limited to a primary cancer type,211183
9/18/2024 13:23,9/18/2024 13:24,IP Address,128.231.234.21,100,66,TRUE,9/18/2024 13:24,R_6gowdRdueUAPYCx,,,,,39.0397,-77.1918,anonymous,EN,University of Texas Southwestern Medical Center SPORE in Kidney Cancer,SPORE - Kidney Cancer,SPORE,DCTD,,,,,,P50CA196516,https://trp.cancer.gov/spores/abstracts/utsouthwestern_kidney.htm  ,,Kidney Cancer,188916
9/18/2024 13:24,9/18/2024 13:25,IP Address,128.231.234.21,100,45,TRUE,9/18/2024 13:25,R_3i2onULidzFpOlO,,,,,39.0397,-77.1918,anonymous,EN,Improving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic Leukemia,SPORE - Health Disparities - Baylor,SPORE,DCTD,,,,,,P20CA262733,https://trp.cancer.gov/spores/abstracts/baylor_p20.htm  ,,"Leukemia,Lymphoma",677262
9/18/2024 13:25,9/18/2024 13:25,IP Address,128.231.234.21,100,33,TRUE,9/18/2024 13:25,R_7TnmTOxsvmJ0cQf,,,,,39.0397,-77.1918,anonymous,EN,Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer,SPORE - Lung Cancer - DF/HCC,SPORE,DCTD,,,,,,P50CA265826,https://trp.cancer.gov/spores/abstracts/dfhcc_lung.htm  ,,Lung Cancer,950430
9/18/2024 13:26,9/18/2024 13:27,IP Address,128.231.234.21,100,24,TRUE,9/18/2024 13:27,R_5335KIetmT0lOqI,,,,,39.0397,-77.1918,anonymous,EN,Translational Research Center in Lung Cancer Disparities,TRACER,SPORE,DCTD,,,,,,P20CA252717,https://trp.cancer.gov/spores/abstracts/vcu_p20.htm  ,,Lung Cancer,993079
9/18/2024 13:27,9/18/2024 13:28,IP Address,128.231.234.21,100,95,TRUE,9/18/2024 13:28,R_3af3dLXOWslam0l,,,,,39.0397,-77.1918,anonymous,EN,Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment,SPORE-Leiomyosarcoma,SPORE,DCTD,,,,,,P50CA272170,https://trp.cancer.gov/spores/abstracts/umich_sarcoma.htm  ,,This program focuses on cancer broadly - not limited to a primary cancer type,171657
9/18/2024 13:37,9/18/2024 13:37,IP Address,128.231.234.21,100,46,TRUE,9/18/2024 13:37,R_6KPmMEuNH9i1n8d,,,,,39.0397,-77.1918,anonymous,EN,NYU Melanoma SPORE,SPORE - Melanoma,Health Disparities,DCTD,,,,,,P50CA225450,https://trp.cancer.gov/spores/abstracts/nyu_skin.htm  ,,Skin Cancer,510228
9/18/2024 13:37,9/18/2024 13:38,IP Address,128.231.234.21,100,30,TRUE,9/18/2024 13:38,R_6AXAvNXGNNSUmSV,,,,,39.0397,-77.1918,anonymous,EN,Melanoma and Skin Cancer Program SPORE,SPORE - Skin Cancer - Pittsburgh,SPORE,DCTD,,,,,,P50CA254865,https://trp.cancer.gov/spores/abstracts/pitt_skin.htm  ,,"Melanoma,Skin Cancer",689027
9/18/2024 13:38,9/18/2024 13:39,IP Address,128.231.234.21,100,32,TRUE,9/18/2024 13:39,R_6qUKRTZT0GLJNx7,,,,,39.0397,-77.1918,anonymous,EN,The University of Texas MD Anderson Cancer Center SPORE in Melanoma,SPORE - Skin Cancer - Texas,SPORE,DCTD,,,,,,P50CA221703,https://trp.cancer.gov/spores/abstracts/mdanderson_skin.htm  ,,Melanoma,100782
9/18/2024 13:39,9/18/2024 13:40,IP Address,128.231.234.21,100,82,TRUE,9/18/2024 13:40,R_5E4JnXSWV0SkPe3,,,,,39.0397,-77.1918,anonymous,EN,SPORE in Skin Cancer,SPORE - Skin Cancer - Wistar,SPORE,DCTD,,,,,,P50CA261608,https://trp.cancer.gov/spores/abstracts/wistar_skin.htm  ,,Skin Cancer,812740
9/18/2024 13:40,9/18/2024 13:41,IP Address,128.231.234.21,100,32,TRUE,9/18/2024 13:41,R_5ebJCfCWIs3MfxD,,,,,39.0397,-77.1918,anonymous,EN,Yale SPORE in Skin Cancer,SPORE - Skin Cancer - Yale,SPORE,DCTD,,,,,,P50CA121974,https://trp.cancer.gov/spores/abstracts/yale_skin.htm  ,,Skin Cancer,254917
9/18/2024 13:41,9/18/2024 13:42,IP Address,128.231.234.21,100,23,TRUE,9/18/2024 13:42,R_5lQfqPntgjv9A53,,,,,39.0397,-77.1918,anonymous,EN,SPORE in Cervical Cancer,SPORE - Cervical Cancer,SPORE,DCTD,,,,,,P50CA098252,https://trp.cancer.gov/spores/abstracts/johnshopkins_gyn.htm  ,,Skin Cancer,937716
9/18/2024 13:42,9/18/2024 13:43,IP Address,128.231.234.21,100,53,TRUE,9/18/2024 13:43,R_5mCNhyaxDPZktt7,,,,,39.0397,-77.1918,anonymous,EN,Route 66 Endometrial Cancer SPORE,SPORE - Endometrial Cancer,SPORE,DCTD,,,,,,P50CA265793,https://trp.cancer.gov/spores/abstracts/wustl_endometrial.htm  ,,Gynecologic Cancer,817147
9/18/2024 13:43,9/18/2024 13:43,IP Address,128.231.234.21,100,43,TRUE,9/18/2024 13:43,R_525XhSxtHeV4c82,,,,,39.0397,-77.1918,anonymous,EN,Johns Hopkins University/University of Pennsylvania SPORE of Ovarian Cancer,SPORE - Ovarian Cancer - JHU/UPenn,SPORE,DCTD,,,,,,P50CA228991,https://trp.cancer.gov/spores/abstracts/johnshopkins_ovarian.htm  ,,Ovarian Cancer,711782
9/18/2024 13:44,9/18/2024 13:44,IP Address,128.231.234.21,100,33,TRUE,9/18/2024 13:44,R_5t4aGJCO9yjUWKl,,,,,39.0397,-77.1918,anonymous,EN,Mayo Clinic Ovarian Cancer SPORE,SPORE - Ovarian Cancer - Mayo,SPORE,DCTD,,,,,,P50CA136393,https://trp.cancer.gov/spores/abstracts/mayo_ovarian.htm  ,,Ovarian Cancer,690897
9/18/2024 13:44,9/18/2024 13:45,IP Address,128.231.234.21,100,26,TRUE,9/18/2024 13:45,R_6JL70zSlFJ1GGPo,,,,,39.0397,-77.1918,anonymous,EN,Roswell Park-University of Chicago Ovarian Cancer SPORE,SPORE - Ovarian Cancer - Roswell/Chicago,SPORE,DCTD,,,,,,P50CA159981,https://trp.cancer.gov/spores/abstracts/roswell_ovarian.htm  ,,Ovarian Cancer,239412
9/18/2024 13:45,9/18/2024 13:47,IP Address,128.231.234.21,100,126,TRUE,9/18/2024 13:47,R_1afMRuqSKjxVMtm,,,,,39.0397,-77.1918,anonymous,EN,HCC Ovarian Cancer SPORE,SPORE - Ovarian Cancer - Pittsburgh,SPORE,DCTD,,,,,,P50CA272218,https://trp.cancer.gov/spores/abstracts/pitt_ovarian.htm  ,,Ovarian Cancer,911275
9/18/2024 13:47,9/18/2024 13:47,IP Address,128.231.234.21,100,27,TRUE,9/18/2024 13:47,R_6erFmPRf9MJQeQ8,,,,,39.0397,-77.1918,anonymous,EN,The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer,SPORE - Ovarian Cancer - Texas,SPORE,DCTD,,,,,,P50CA281701,https://trp.cancer.gov/spores/abstracts/mdanderson_ovarian.htm  ,,Ovarian Cancer,297160
9/18/2024 13:48,9/18/2024 13:48,IP Address,128.231.234.21,100,28,TRUE,9/18/2024 13:48,R_6qK9wlbsAA4S7hH,,,,,39.0397,-77.1918,anonymous,EN,Reducing Cancer Health Disparities in Detroit,SPORE - Health Disparities - WSU,"SPORE,Health Disparities",DCTD,,,,,,P20CA262735,https://trp.cancer.gov/spores/abstracts/wayne_state_p20.htm  ,,This program focuses on cancer broadly - not limited to a primary cancer type,971620
9/18/2024 13:48,9/18/2024 13:49,IP Address,128.231.234.21,100,47,TRUE,9/18/2024 13:49,R_3mZgTXr9O2OQaWt,,,,,39.0397,-77.1918,anonymous,EN,Baylor College of Medicine SPORE in Lymphoma,SPORE - Lymphoma Cancer - Baylor,SPORE,DCTD,,,,,,P50CA126752,https://trp.cancer.gov/spores/abstracts/baylor_lymphoma.htm  ,,Lymphoma,422695
9/18/2024 13:50,9/18/2024 13:51,IP Address,128.231.234.21,100,31,TRUE,9/18/2024 13:51,R_5QutEFo5LI7AWaq,,,,,39.0397,-77.1918,anonymous,EN,Dana-Farber/Harvard Cancer Center SPORE in Multiple Myeloma,SPORE - Myeloma Cancer - DF/HCC,SPORE,DCTD,,,,,,P50CA100707,https://trp.cancer.gov/spores/abstracts/dfhcc_myeloma.htm  ,,Multiple Myeloma,973231
9/18/2024 13:51,9/18/2024 13:51,IP Address,128.231.234.21,100,28,TRUE,9/18/2024 13:51,R_1Ea2NqiKJFJIzeD,,,,,39.0397,-77.1918,anonymous,EN,Mayo Clinic Multiple Myeloma SPORE,SPORE - Myeloma Cancer - Mayo,SPORE,DCTD,,,,,,P50CA186781,https://trp.cancer.gov/spores/abstracts/mayo_myeloma.htm  ,,Multiple Myeloma,640799
9/18/2024 13:52,9/18/2024 14:03,IP Address,128.231.234.21,100,657,TRUE,9/18/2024 14:03,R_5e8jcp2u9VTS6pB,,,,,39.0397,-77.1918,anonymous,EN,The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer,SPORE - Pancreas Cancer - MSKCC,SPORE,DCTD,,,,,,P50CA257881,https://trp.cancer.gov/spores/abstracts/mskcc_pancreas.htm  ,,Pancreas Cancer,372122
9/18/2024 14:03,9/18/2024 14:03,IP Address,128.231.234.21,100,26,TRUE,9/18/2024 14:03,R_5Lb8N8KGj413YH4,,,,,39.0397,-77.1918,anonymous,EN,Selective Targeting of Pancreatic Cancer SPORE,SPORE - Pancreas Cancer - UNC,SPORE,DCTD,,,,,,P50CA257911,https://trp.cancer.gov/spores/abstracts/unc_pancreas.htm  ,,Pancreas Cancer,371521
9/18/2024 14:04,9/18/2024 14:04,IP Address,128.231.234.21,100,26,TRUE,9/18/2024 14:04,R_3MS87B7UZYVLtdv,,,,,39.0397,-77.1918,anonymous,EN,Washington University SPORE in Pancreatic Cancer,SPORE - Pancreas Cancer - WUSTL,SPORE,DCTD,,,,,,P50CA272213,https://trp.cancer.gov/spores/abstracts/wustl_pancreatic.htm  ,,Pancreas Cancer,567889
9/18/2024 14:04,9/18/2024 14:05,IP Address,128.231.234.21,100,25,TRUE,9/18/2024 14:05,R_11gtQcZMapVWST2,,,,,39.0397,-77.1918,anonymous,EN,Dana-Farber Harvard Cancer Center SPORE in Prostate Cancer,SPORE - Prostate Cancer - DF/HCC,SPORE,DCTD,,,,,,P50CA272390,https://trp.cancer.gov/spores/abstracts/dfhcc_prostate.htm  ,,Prostate Cancer,396592
9/18/2024 14:05,9/18/2024 14:05,IP Address,128.231.234.21,100,26,TRUE,9/18/2024 14:05,R_7lWjifcochAM3nv,,,,,39.0397,-77.1918,anonymous,EN,The Pacific Northwest Prostate Cancer SPORE,SPORE - Prostate Cancer - Fred Hutch,SPORE,DCTD,,,,,,P50CA097186,https://trp.cancer.gov/spores/abstracts/fhcrc_prostate.htm  ,,Prostate Cancer,467434
9/18/2024 14:05,9/18/2024 14:07,IP Address,128.231.234.21,100,112,TRUE,9/18/2024 14:07,R_6F4HPCIj06a1sEL,,,,,39.0397,-77.1918,anonymous,EN,SPORE in Prostate Cancer,SPORE - Prostate Cancer - Northwestern,SPORE,DCTD,,,,,,P50CA180995,https://trp.cancer.gov/spores/abstracts/northwestern_prostate.htm  ,,Prostate Cancer,457809
9/18/2024 14:07,9/18/2024 14:07,IP Address,128.231.234.21,100,23,TRUE,9/18/2024 14:08,R_5RsDfyNM6ihlsqJ,,,,,39.0397,-77.1918,anonymous,EN,SPORE in Prostate Cancer (MSKCC),SPORE - Prostate Cancer - MSKCC,SPORE,DCTD,,,,,,P50CA092629,https://trp.cancer.gov/spores/abstracts/mskcc_prostate.htm  ,,Prostate Cancer,887958
9/18/2024 14:08,9/18/2024 14:08,IP Address,128.231.234.21,100,32,TRUE,9/18/2024 14:08,R_3HklcJih9qCJKuq,,,,,39.0397,-77.1918,anonymous,EN,UCLA SPORE in Prostate Cancer,SPORE - Prostate Cancer - UCLA,SPORE,DCTD,,,,,,P50CA092131,https://trp.cancer.gov/spores/abstracts/ucla_prostate.htm  ,,Prostate Cancer,328862
9/18/2024 14:08,9/18/2024 14:09,IP Address,128.231.234.21,100,28,TRUE,9/18/2024 14:09,R_7IyCAOJrAnyVJol,,,,,39.0397,-77.1918,anonymous,EN,Michigan Prostate SPORE,SPORE - Prostate Cancer - Michigan,SPORE,DCTD,,,,,,P50CA186786,https://trp.cancer.gov/spores/abstracts/umich_prostate.htm  ,,Prostate Cancer,258729
9/18/2024 14:09,9/18/2024 14:09,IP Address,128.231.234.21,100,24,TRUE,9/18/2024 14:09,R_5LNzJD9R3s0iCnI,,,,,39.0397,-77.1918,anonymous,EN,University of Wisconsin Prostate SPORE,SPORE - Prostate Cancer - Wisconsin,SPORE,DCTD,,,,,,P50CA269011,https://trp.cancer.gov/spores/abstracts/wisconsin_prostate.htm  ,,Prostate Cancer,652889
9/18/2024 14:09,9/18/2024 14:10,IP Address,128.231.234.21,100,24,TRUE,9/18/2024 14:10,R_3zUSatzxxBN4P8S,,,,,39.0397,-77.1918,anonymous,EN,Molecularly Targeted Radiosensitization of Locally Advanced Cancers,SPORE - Radiation Therapy,SPORE,DCTD,,,,,,P50CA269022,https://trp.cancer.gov/spores/abstracts/umich_radiosensitization.htm  ,,This program focuses on cancer broadly - not limited to a primary cancer type,500095
9/18/2024 14:10,9/18/2024 14:10,IP Address,128.231.234.21,100,23,TRUE,9/18/2024 14:10,R_6zpBnWRfnHfoakz,,,,,39.0397,-77.1918,anonymous,EN,SPORE in Soft Tissue Sarcoma,SPORE - Sarcoma Cancer,SPORE,DCTD,,,,,,P50CA217694,https://trp.cancer.gov/spores/abstracts/mskcc_sarcoma.htm  ,,Sarcoma,968424
